Introduction {#Sec1}
============

Earlier reviews on the safety of *Aspergillus niger*, *Aspergillus oryzae*, and *Trichoderma reesei* have been published (Schuster et al. [@CR405]; Tanaka et al. [@CR442]; Barbesgaard et al. [@CR29]; Jørgensen [@CR196]; Blumenthal [@CR39]), but since these reviews were written, much progress has been made in the taxonomy, toxicology, natural product chemistry, genomics, genetics, and molecular biology of these fungi.

There is a clear distinction between mycotoxins and other secondary metabolites with attractive properties for diverse applications. Fungal species containing industrial strains have the potential to produce a rather limited number of compounds that are toxic to vertebrates (mycotoxins) and a large variety of other compounds that can display anticarcinogenic or antimicrobial activity, antioxidant activity, be pigments, etc. (Mushtaq et al. [@CR308]). A clear definition of mycotoxin and secondary metabolite is presented here to provide a clear basis for the consideration of safety. The fungal strains that represent the workhorses of industrial biotechnology have a long and extensively documented history of safe use for food and feed applications. Strains belonging to the *Aspergillus* species *A. niger* and *A. oryzae* have been used for fermentation of food for more than 2 millennia and to manufacture food enzymes for over 50 years, while strains of *Trichoderma reesei* have been used safely for decades in enzyme production. Hundreds of enzymes produced in these species are considered as safe by regulatory authorities. Furthermore, mycotoxins and other secondary metabolites are not produced during the controlled, industrially relevant growth conditions where nutrients are not limited and where there is no growth challenge by any other microorganism.

This report includes a comprehensive update of the current knowledge about the mycotoxin and the promising secondary metabolite potential of these industry relevant fungal species. We have considered all published work and have critically evaluated the validity of the data and the accuracy of the taxonomic identification in each case. Consequently, not all publications have been included herein. The report is divided into three sections (taxonomy, mycotoxins, and secondary metabolite potential) for each species.

Taxonomy of *Aspergillus niger*, *Aspergillus oryzae*, and *Trichoderma reesei* {#Sec2}
===============================================================================

Traditional identification of fungal species relied on microscopic and macroscopic morphological traits, e.g., sporulation structures and other phenotypic features like growth and colony features (see Fig. [1](#Fig1){ref-type="fig"} for examples of *A. niger*, *A. oryzae*, and its close relative *Aspergillus flavus*, together with *T. reesei*). In the last decades, taxonomical classification aided by secondary metabolite profiles has also proven successful (Frisvad and Larsen [@CR105]; Samson et al. [@CR395]). More recently, the use of diagnostic gene sequences like rRNA and, later, the availability of whole genome sequences, have enabled direct comparison of different species at the nucleotide level, throughout the genome. In fact, rDNA-derived ITS sequences are recommended as one of the main "barcodes" for species identification (Samson et al. [@CR395]). However, at least in some *Aspergillus* clades, there is limited variation in, e.g., ITS sequences, requiring the use of additional barcodes like calmodulin or β-tubulin (Samson et al. [@CR395]). The level of resolution of these molecular techniques provides new ways to investigate what defines the species boundaries (Vesth et al. [@CR480]). Still, differences in DNA sequences alone cannot always provide a biological understanding. Also, the profiles of secondary metabolites are species-specific (Frisvad and Larsen [@CR105]) and thereby consistent with phylogenetic relationships in fungi (Larsen et al. [@CR236]; Kocsubé et al. [@CR223]). When taxonomical identification is required, it is therefore advantageous to combine the accumulated knowledge on morphological, physiological, and molecular characteristics. Taxonomical classification of *A. niger*, *A. oryzae*, and *T. reesei* together with relevant related species is described in the following texts.Fig. 1Macroscopic characteristics of 7-day old fungal species growing on solid medium (CYA). **a** *Aspergillus niger*; **b** *A. oryzae*; **c** *A. flavus*; **d** *Trichoderma reesei* (Photo: Birgitte Andersen)

*Aspergillus niger* {#Sec3}
-------------------

*Aspergillus niger* is placed within the *Aspergillus niger* clade in the *Aspergillus* section *Nigri* (Varga et al. [@CR473]). The species is well-circumscribed, but it has a sibling species, with the same properties, called *Aspergillus welwitschiae* (Hong et al. [@CR173]). The latter species shares all morphological, physiological, and chemical characters with *A. niger* (Fig. [1](#Fig1){ref-type="fig"}), and the two species can only be distinguished by sequencing preferably one of the secondary bar-coding genes (Hong et al. [@CR174]). The DNA barcodes of *Aspergillus welwitschiae* are as follows: ITS (internally transcribed spacer regions and the 5.8 S of the ribosomal gene): FJ629340; BenA (β-tubulin): FJ629291; CaM (calmodulin): KC480196, while *A. niger* has the following barcodes: ITS: EF 661186; BenA (β-tubulin): EF661089; CaM (calmodulin): EF661154; RPB2 (RNA polymerase B2: EF661058). Different strains of *Aspergillus niger* have been genome-sequenced (see Baker [@CR24]; Pel et al. [@CR342]; Andersen et al. [@CR13]).

Other species closely related to *A. niger* are *Aspergillus neoniger*, *Aspergillus tubingensis*, *Aspergillus vadensis*, *Aspergillus luchuensis*, *Aspergillus eucalypticola*, *Aspergillus costaricaensis*, and *Aspergillus piperis*, but it is mostly *A. luchuensis* (formerly *Aspergillus acidus* or *Aspergillus foetidus* var. *acidus*), *A. vadensis*, and *A. tubingensis* that are used in the industry. In some cases, the latter have been misidentified as *A. niger*, and *A. niger* is by far most commonly used species in the industry (Frisvad et al. [@CR107]). *A. luchuensis* is found in fermented Puerh tea (Mogensen et al. [@CR299]) and is used often for koji production (also under the names *Aspergillus kawachii* and *Aspergillus awamori*) (Fujimoto et al. [@CR113]; Hong et al. [@CR173]; Fujii et al. [@CR112]). *A. niger* sensu stricto is the most commonly used species in biotechnology (Andersen et al. [@CR13]; Frisvad et al. [@CR107]). An often examined typical strain of *A. niger* is ATCC 1015.

Unlike the situation in *A. flavus*, which has a taxonomically accepted domesticated form *A. oryzae*, the domesticated form of *A. niger*, *A. awamori* (Nakazawa [@CR316], Sakaguchi et al. [@CR385]; Raper and Fennell [@CR373]; Murakami [@CR307]; Al-Musallam [@CR10]), has not been accepted as a valid name, probably because of a mistaken neotypification. Perrone et al. ([@CR343]) used the name *A. awamori* for a taxon that was isolated from *Welwitschia mirabilis*, but since the ex-type isolate (CBS 557.65) was not from a koji environment, that species was renamed *A. welwitschiae* by Hong et al. ([@CR173]). Other names such as *Aspergillus usamii* and *A. kawachii* have also been used for domesticated forms of *A. niger* or *A. luchuensis* (Hong et al. [@CR174]). However, none of these names have been officially taken up for the domesticated form of *A. niger*. The names *Aspergillus phoenicis* and *Aspergillus ficuum* predate *A. niger* and have therefore been rejected, and the name *A. niger* officially conserved because of the economical importance of the latter species (Kozakiewicz et al. [@CR229]).

Average nucleotide identity (ANI) has become the gold standard for taxonomic confirmation of prokaryotes. Two species having \> 95% ANI are considered the same species (Rodriguez and Konstantinidis [@CR379]). Although ANI is not widely used in eukaryotes and there are no studies done to layout an ANI-based species framework in fungi, ANI values can still be used to determine the relatedness of two strains or species and can give a better resolution of phylogenetic tree-based inferences (Goris et al. [@CR136]). ANI can also discriminate between closely related populations, and it provides a higher resolution than other sequence analyses, at least in bacteria (Rodriguez and Konstantinidis [@CR379]).

We performed comparative genomics within species of the *Nigri* clade for which the genome sequence is available using ANI that showed a relatively high identity (85% or higher) between different species in this clade, while a lower level (\~ 76%) was obtained when comparing to species outside the clade like *A. oryzae* or *Aspergillus nidulans* (Table [1](#Tab1){ref-type="table"}). Remarkably, a higher ANI was obtained when comparing *A. tubingensis* and *A. luchuensis* (\~ 93%) and a slightly lower ANI when comparing *A. tubingensis* with *A. vadensis* or *A. luchuensis* with *A. vadensis* (\~ 92%). These three species appear to be more closely related (Table [1](#Tab1){ref-type="table"}), and they all produce asperazines (Nielsen et al. [@CR321]). A phylogenetic tree based on the above-mentioned genome comparison displays the closer relationship between these three species and the clustering of *A. niger* and *Aspergillus brasiliensis* (Fig. [2](#Fig2){ref-type="fig"}).Table 1Reciprocal average nucleotide identity (ANI, Goris et al. [@CR136]) of relevant *Aspergillus* species. A standalone version of the software was downloaded from <http://enve-omics.ce.gatech.edu/ani/>. Pair-wise comparisons of different combinations were performed using R script and phyton programmingStrain*A. oryzae* A1560*A. oryzae* RIB40*A. flavus* NRRL3357*A. niger* CBS513.88*A. brasiliensis* CBS101740*A. tubingensis* CBS134.48*A. luchuensis* NBRC 4314*A. vadensis* CBS 113365*A. nidulans* FGSCA4*A. oryzae* A1560100.00\|0.0099.94\|0.8599.14\|1.7577.77\|5.7677.63\|5.2277.46\|5.4877.24\|4.9077.20\|5.0876.28\|4.68*A. oryzae* RIB4099.97\|0.34100.00\|0.0099.16\|1.6179.00\|7.1978.09\|5.6177.95\|5.6477.42\|5.2177.60\|5.3976.31\|4.72*A. flavus* NRRL335799.18\|1.5299.18\|1.49100.00\|0.0077.44\|5.1577.51\|5.0277.54\|5.3977.41\|4.9977.14\|4.9876.28\|4.72*A. niger* CBS513.8877.84\|6.0178.35\|6.6677.45\|5.31100.00\|0.0085.67\|5.1886.87\|5.2386.78\|5.1986.89\|5.2377.02\|4.95*A. brasiliensis* CBS10174077.59\|5.0977.61\|5.1477.49\|5.0085.67\|5.18100.00\|0.0085.18\|5.1385.08\|5.1085.17\|5.1377.16\|5.37*A. tubingensis* CBS134.4877.43\|5.4177.49\|5.4077.53\|5.4086.85\|5.2485.17\|5.14100.00\|0.0093.25\|4.4492.54\|4.7676.91\|4.95*A. luchuensis* NBRC 431477.30\|4.9077.53\|5.3377.38\|4.9586.77\|5.1985.09\|5.0993.28\|4.39100.00\|0.0092.12\|4.6376.85\|4.94*A. vadensis* CBS 11336577.10\|5.0477.17\|5.0077.12\|4.9886.86\|5.2685.16\|5.1392.53\|4.7892.07\|4.72100.00\|0.0077.04\|4.93*A. nidulans* FGSCA476.30\|4.7376.31\|4.7376.25\|4.7277.00\|4.9777.15\|5.3576.84\|4.9976.79\|4.9577.05\|4.93100.00\|0.00Fig. 2Phylogram based on whole genome sequences of available *Aspergillus* species within the *Nigri* and *Flavi* clades. The phylogram was made using kSNP (version 3.1; Gardner et al. [@CR123]) which computes a core SNP matrix from all the genomes and then executed FastTree (Price et al. [@CR354]) with the maximum likelihood option to compute the tree. The tree was then midpoint-rooted and rendered as a Phylogram using Dendroscope (Huson and Scornavacca [@CR180])

Recently, wild-type *A. niger* has been considered as a class 2 microorganism by the German authorities (BAUA see previous texts) because of its potential mycotoxin production and pathogenicity to humans and animals. It is important to discriminate between (1) mycotoxin production as a health hazard during food manufacture and spoilage and corn silage and (2) the growing number of reports of opportunistic pathogens that have resulted in disease, normally in immunocompromised patients. In fact, the baker's yeast (*Saccharomyces cerevisiae*) can also be considered as a pathogen since it has been associated with disease in severely immunocompromised patients. Perhaps the concept of what constitutes a "pathogen" needs a comprehensive revision and it is not solely related to the taxonomy of the microbe (Casadevall and Pirofski [@CR59]).

*Aspergillus oryzae* {#Sec4}
--------------------

*A. oryzae* is regarded by most taxonomists as the domesticated form of *A. flavus* (Blochwitz [@CR38]; Wicklow [@CR494]; Klich and Pitt [@CR216]; Georgianna et al. [@CR127]; Rokas [@CR381]; Varga et al. [@CR475]; Gibbons et al. [@CR129]; Houbraken et al. [@CR176]; Frisvad et al. [@CR104]). Wicklow ([@CR494]) claims that domestication (in rice fermentations) has resulted in the following phenotypic differences: conidia in *A. oryzae* are smoother and slightly larger (to adapt to the rice habitat), amylase production is higher, the conidiophore stipes are longer, the mycelium is more floccose, and the conidium color *en masse* is light brownish green rather than yellow grass green as compared to *A. flavus* (Fig. [1](#Fig1){ref-type="fig"}). While there are no genotypic differences between *A. oryzae* and *A. flavus* (Thom and Church [@CR452]; Raper and Fennell [@CR373]; Murakami [@CR306]; Christensen [@CR68]; Pitt et al. [@CR348]; Wicklow [@CR494]; Klich and Pitt [@CR215], [@CR216]; Geiser et al. [@CR126], [@CR125]; Gibbons et al. [@CR129]; Powell et al. [@CR352]; Varga et al. 2011; Gilbert et al. [@CR130]; Frisvad et al. [@CR104]), there are several morphological and physiological differences between the two species as listed previously. Furthermore *Aspergillus oryzae* cannot produce aflatoxins, aspergillic acid, and flavimine, that are otherwise present in most strains of *Aspergillus flavus* (Thom and Church [@CR452]; Raper and Fennell [@CR373]; Murakami [@CR306]; Christensen [@CR68]; Wicklow [@CR494]; Klich and Pitt [@CR215], [@CR216]; Pitt et al. [@CR348]; Varga et al. 2011; Frisvad et al. 2018; Fig. [1](#Fig1){ref-type="fig"}). Klich and Mullaney ([@CR214]) were able to distinguish between strains of *A. oryzae* and *A. flavus* by DNA restriction enzyme fragment polymorphisms. Nearly all strains of *A. flavus* produce a bright orange reverse on the medium AFPA (*Aspergillus flavus parasiticus* agar), while *A. oryzae* strains produce a cream-colored reverse (Bothast and Fennell [@CR40]; Hamsa and Ayres [@CR147]; Pitt et al. [@CR348]).

In accordance with this, genome sequencing of *A. flavus* (Nierman et al. [@CR322]; Faustinelli et al. [@CR98]) and strains of *A. oryzae* (Machida et al. [@CR271]; Galagan et al. [@CR117]; Umemura et al. [@CR466], [@CR467],[@CR465]; Zhao et al. [@CR527], [@CR526],[@CR523], [@CR524],[@CR525]) have shown that these two species are very similar. Interestingly, the first sequenced strain of *A. oryzae* may be an *A. flavus* "sensu stricto." The isolate RIB40 produces large globose sclerotia (Rank et al. [@CR368]; Fig. [1](#Fig1){ref-type="fig"}) and was isolated from a broad bean, Kuriyamacho, Kyoto, Japan, in a field, not from a fermentation factory. Based on the first identification as *A*. *oryzae* var. *brunneus*, it has brownish conidia and, therefore, resemble *A. oryzae*. RIB40 does not produce aflatoxin as it contains disabling mutations in the gene cluster (Tominaga et al. [@CR455]). It has been shown that *A. flavus* isolates gradually lose their ability to produce spores, sclerotia, and aflatoxin-producing capability after several serial transfers (Torres et al. [@CR456]; Horn and Dorner [@CR175]; Chang et al. [@CR62]). The production of large globose sclerotia is characteristic for *A. flavus* sensu stricto (Geiser et al. [@CR125]), and only few strains of *A. flavus* (for example NRRL 3251) produce small sclerotia (Hesseltine et al. [@CR166]; Saito and Tsuruta [@CR384]), while other strains with small sclerotia belong to the species *Aspergillus minisclerotigenes*, *Aspergillus aflatoxiformans*, *Aspergillus austwickii*, and *Aspergillus cerealis* (Varga et al. 2011; Frisvad et al. 2018). Overall, none of the characterized true *A. oryzae* isolates produce aflatoxins. For *A. flavus*, the situation is more complex since some isolates, including the ex-type strain (NRRL1957), do not produce aflatoxin. However, aflatoxin production has been shown for a large number of *A. flavus* including NRRL3357.

Genome sequencing has allowed several comparative studies to be carried out (Abe et al. [@CR3]; Payne et al. [@CR341]; Kobayashi et al. [@CR219]; Rokas et al. [@CR382]; Machida et al. [@CR272]). *A. oryzae* is used extensively in enzyme production at industrial scale (Barbesgaard et al. [@CR29]; Jørgensen [@CR196]) and as a successful expression host for production of secondary metabolites (Sakai et al. [@CR388]; Liu et al. [@CR257]; Minami et al. [@CR293]; He et al. [@CR160]). In practice, sequence barcodes for *A. oryzae* include the following: (1) ITS (accession no. EF661560); (2) BenA (β-tubulin, accession no. EF661483); (3) CaM (calmodulin accession no. EF661506); and (4) RPB2 (RNA polymerase B2, accession no. EF661438) and for *A. flavus*: (1) ITS: (AF027863); (2) BenA (EF661485); (3) CaM (EF661508); and RPB2 (EF661440). Remarkably, the barcodes are not sufficient to effectively separate *A. flavus* and *A. oryzae*. More elaborate molecular techniques are required to distinguish these species (Godet and Munaut [@CR135]). ANI analysis showed a very high degree of sequence homology, well above 99%, between RIB40 and other *A. oryzae* strains used in industrial enzyme production like A1560 (synonym IFO 4177), while a slightly lower percentage is observed when comparing *A. flavus* and *A. oryzae* (Table [1](#Tab1){ref-type="table"}). The use of the % identity between *A. oryzae* RIB40, A1560 or *A. flavus* NRRL3357 (99.9% versus 99.1%) does not allow a direct species discrimination based on ANI. Furthermore, ANI between *A. oryzae* and species from the *Nigri* section display an ANI value below 80%. Members of the *Nigri* section display an ANI of 85% or higher. Lower ANI (approx. 75%) is obtained when comparing either *A. oryzae*/*A. flavus* to *A. nidulans* or species from the *Nigri* section to *A. nidulans*. Overall, as in the case of *A. niger*, the above-mentioned data demonstrate that genome homology data alone cannot be used for taxonomical purposes and need to be complemented by phenotypic properties.

*Trichoderma reesei* {#Sec5}
--------------------

*Trichoderma reesei* (anamorph) has also been named *Hypocrea jecorina* (teleomorph and holomorph), but with the new nomenclatural system used after 2011, *Trichoderma reesei* is considered the correct name for this fungus (Samuels et al. [@CR397]; Samuels et al. [@CR396], Fig. [1](#Fig1){ref-type="fig"}). Most of the industrial strains have a single common ancestor, RUT-C30, which displays a blue-green color on solid medium (Fig. [1](#Fig1){ref-type="fig"}). The genome sequence has also been reported for this species (Martinez et al. [@CR277]). The *T. reesei* type strain is QM6a.

Mycotoxins are a very limited group of fungal secondary metabolites {#Sec6}
===================================================================

Fungal secondary metabolites can be defined as outward-directed, small differentiational molecules of restricted taxonomic distribution that are genetically encoded by clustered genes and accumulated and normally secreted. Secondary metabolites are a very heterogeneous chemical group of low molecular weight compounds that include antimicrobials, antioxidants, pigments, hormones, and metal chelators. A great number of these compounds have therefore a very significant potential application.

In general, any competition-selected fungal species has the potential to produce hundreds of individual secondary metabolites coded by up to 90 biosynthetic gene clusters (Clevenger et al. [@CR71]; Lind et al. [@CR251]). The major biosynthetic classes of secondary metabolites are polyketides, non-ribosomal peptides, terpenes, and shikimic acid-derived compounds, but many compounds are hybrids of these classes. The genes coding for the enzymes involved in the biosynthesis of these compounds are associated in gene clusters. The genomes of *A. niger*, *A. oryzae*, and *T. reesei* include 78, 75, and 27 gene clusters for secondary metabolite biosynthesis, respectively (Lind et al. [@CR252]; Zeilinger et al. [@CR514]; Wasil et al. [@CR489]), although these numbers may vary depending on the strain and the software package used. Furthermore, each biosynthetic gene cluster may be responsible for the production of a large number of precursors, shunt products, and final products. For example *Aspergillus oryzae* was reported to produce many members (26) of the cyclopiazonic acid biosynthetic family of compounds (Liu et al. [@CR253]), including cyclopazonic acids, speradines, cyclopiamides, and asporydines. With the development of new genome mining approaches (Kjærbølling et al. [@CR212]) and algorithms such as antiSMASH (Blin et al. [@CR37]), the prediction of secondary metabolite encoding gene clusters has become easier. On the other hand, the chemical modifications based on important accessory tailoring genes on the core structure of secondary metabolites may be more difficult to predict from sequences (Bertrand et al. [@CR34]) and often require full structure elucidation. In this context, it is important to note that majority of gene clusters are not expressed under standard cultivation and that no fungal species synthesizes all potential secondary metabolites at any given time. As mentioned previously, production of secondary metabolites does not normally occur under production-relevant growth conditions where no species competition or nutrient starvation threat is used.

Mycotoxins are a very limited group of fungal secondary metabolites. Regarding biotechnology, mycotoxins are important if they pose a safety concern in the industrial application of fungi for enzyme or bulk metabolite production as well as in other areas like food spoilage and in building environments. There have been numerous definitions of the word mycotoxin (Bennett and Inamdar [@CR31]; Taevernier et al. [@CR432]), but a strict consensus definition that we endorse is the following: Mycotoxins are secondary metabolites genetically encoded by clustered genes and produced by fungi. These mycotoxins are acutely or chronically toxic and pose health hazards or death in humans and other vertebrates when acquired in small amounts via a natural route (orally, by inhalation, or via the skin). This definition is a combination of that of Jarvis and Miller ([@CR191]), Frisvad ([@CR103]), Bennett and Inamdar ([@CR31]), and Taevernier et al. ([@CR432]). Taevernier et al. ([@CR432]) suggested that a quantitative level of cell cytotoxicity on preferably human cell cultures with an IC~50~ (the concentration required for 50% of cell viability) of less than 1000 μM could be used to determine whether a fungal secondary metabolite was considered a mycotoxin or not. We cannot accept this definition as such molecules may be cytotoxic, while not necessarily being toxic when acquired via a natural route. Earlier claims of mycotoxicity were based on other toxicity data, such as toxicity including cancerogenicity after intraperitoneal or subcutaneous injection (Dickens and Jones [@CR80]; Cole and Cox [@CR72]; Lu et al. [@CR261]), but this too is not a natural route of intake. For example, patulin and penicillic acid were originally claimed to be cancerogenic based on subcutaneous injection (Dickens and Jones [@CR80]), but Enomoto and Saito ([@CR95]) rightly mention that experimental production of cancer should be confirmed in animals by oral administration of mycotoxin.

The safe use of fungal strains is recognized in official classifications of biological agents into risk groups; e.g., BAUA (German Federal Institute for Occupational Safety and Health) classifies *A. niger* and *A. oryzae* as risk group 2 biological agents. Importantly, BAUA recognizes that strains belonging to these species may still be classified as risk group 1 biological agents if documentation of safety and/or history of safe use is provided.

In the following sections, we describe the mycotoxins that are potentially produced by the three industrial organisms and relevant related species. Only mycotoxins with a documented effect are described. All other secondary metabolites are described in the section on secondary metabolite potential and are not considered mycotoxins according to the definition herein.

Mycotoxins potentially produced by *Aspergillus niger* {#Sec7}
------------------------------------------------------

*Aspergillus niger* has been claimed to produce a very large number of mycotoxins and other secondary metabolites (Table [2](#Tab2){ref-type="table"}; Nielsen et al. [@CR321]). Apart from a large number of volatiles and small organic acids (Wani et al. [@CR488]; Priegnitz et al. [@CR355]; Costa et al. [@CR75]), *A. niger* sensu stricto can produce very few mycotoxins but a large number of other secondary metabolites. In many cases, fungi identified as *A. niger* were indeed *A. tubingensis* or other closely related species (Table [2](#Tab2){ref-type="table"}).Table 2Mycotoxins from *Aspergillus niger* (and its sibling species *A. welwitschiae*) (Nielsen et al. [@CR321])MycotoxinReferenceCommentFumonisin B~2~Frisvad et al. ([@CR110], [@CR107])This mycotoxin has been found in more than 75% of strains examined of *A. niger* (Frisvad et al. [@CR107])Fumonisin B~4~Mogensen et al. ([@CR298]); Månsson et al. ([@CR274])Fumonisin B~6~Månsson et al. ([@CR274])Ochratoxin AAbarca et al. ([@CR1])This mycotoxins has been found in less than 10% of the strains of *A. niger* examined (Frisvad et al. [@CR107])Oxalic acidRaistrick and Clark ([@CR364]); Yassin et al. ([@CR506])Nearly all strains of *A. niger* produce oxalic acid

Fumonisins {#Sec8}
----------

Fumonisins are strongly reduced polyketides with two added tricaballyllic acid groups and an amino group added from a non-ribosomal peptide. They are mycotoxins associated with multiple human and animal diseases, as they are produced in large amounts in cereals by common *Fusarium* species (Braun and Wink [@CR43]; Cendoya et al. [@CR60]). Fumonisins induce leukoencephalomalacia in horses, nephro- and hepato-toxicity in rodents, and pulmonary toxicity in pigs, and they have been classified as International Agency for Research on Cancer (IARC) type 2B carcinogens in humans (esophageal cancer) (Cendoya et al. [@CR60]). However, *Aspergillus niger* and its sibling species *A. welwitschiae* (originally named *A. awamori*) also produce fumonisins of the B~2~, B~4~, and B~6~ types (Frisvad et al. [@CR110]; 2010) and may produce fumonisins in cereals and grapes (Logrieco et al. [@CR258]; Mogensen et al. [@CR298]; Munkvold et al. [@CR305]). Several industrial strains have the capability to produce fumonisins (Frisvad et al. 2010; Han et al. [@CR148]), so it is important to use strains that do not produce these mycotoxins. Current *A. niger* production strains have been developed that either have been selected due to the lack of fumonisin production or contain a deletion of the fumonisin gene cluster (unpublished results).

The impact of fumonisins on human health remains poorly understood (Voss and Riley [@CR482]). It has been known for long that fumonisins are hepatotoxic, nephrotoxic, atherogenic (induces formation of plaque in arteries), immunosuppressive, and embryotoxic in experimental animal systems (Nair [@CR310]). Structurally, fumonisin B1 shows similarity to the cellular sphingolipids, and this similarity has been shown to disturb the metabolism of sphingolipids leading to accumulation of sphinganine in cells and tissues. The cellular mechanisms behind fumonisin B~1~-induced toxicity include the induction of oxidative stress, apoptosis, and cytotoxicity, as well as alterations in cytokine expression (Stockmann-Juvala and Savolainen [@CR424]). Mechanistically, the toxicity of fumonisin B~2~ and B~3~ is relatively poorly understood, but a comparison of the toxicities of fumonisin B~1~, B~2~, and B~3~ individually and in combination has shown that all three are toxic, but with fumonisin B~1~ being the most toxic of the three (Henry and Wyatt [@CR165]).

Ochratoxin {#Sec9}
----------

Ochratoxin A (OTA) is a mycotoxin that is a common contaminant of a wide variety of food products. The molecular structure comprises a chlorinated polyketide dihydroisocoumarin ring linked to phenylalanine and, as shown in different producing fungal species, a polyketide synthase (PKS) is a major part of the biosynthetic pathway (Wang et al. [@CR487]; Massi et al. [@CR280]; Gallo et al. [@CR122]; Gill-Serna et al. [@CR132]). OTA inhibits protein synthesis and energy production, induces oxidative stress, cell apoptosis and necrosis, and DNA adduct formation, and is mostly recognized as a nephrotoxin (Heussner and Bingle [@CR167]; Közégi and Poór [@CR230]). It is classified as an IARC type B2 carcinogen in human beings.

Oxalic acid {#Sec10}
-----------

Oxalic acid is a strong dicarboxylic acid. Oxalic acid is a reducing agent and its conjugate base, known as oxalate, is a chelating agent for metal cations. Typically, oxalic acid occurs as the dihydrate. Excessive ingestion of oxalic acid or prolonged skin contact can be dangerous. Oxalic acid is hepatotoxic, but it will only have a negative effect in quite high doses (Jahn [@CR188]). *Aspergillus niger* infections are often accompanied with oxalosis (Kredics et al. [@CR231]; Oda et al. [@CR330]), and in one case, calcium oxalate produced by *A. niger* in the lungs caused hyperoxaluria in the kidneys (Vaideeswar and Sakhdeo 2009), so both kidneys and the liver can be affected. However, such cases are rare and will only happen in severely immunocompromised patients. Otomycoses are often caused by *Aspergillus tubingensis* rather than *A. niger* (Kredics et al. [@CR231]).

Improved safety of *A. niger* industrial strains {#Sec11}
------------------------------------------------

As mentioned previously, *A. niger* has the potential to produce ochratoxin, fumonisin, and oxalic acid. Industrial strains have been developed by classical mutagenesis and by deletion of the genes involved in the biosynthesis (Susca et al. [@CR431]).

Mycotoxins from *Aspergillus oryzae* and *A. flavus* {#Sec12}
----------------------------------------------------

*A. oryzae* and its closely related species *A. flavus* can produce a very limited number of mycotoxins (Table [3](#Tab3){ref-type="table"}). Their macroscopic similarity has contributed to a disparity of reports on the potential production of mycotoxins from either species. Mycotoxins produced by these species are described in the following texts with attention to knowledge about the potential production of these compounds by either species and reports that describe production in wrongly assigned species.Table 3Mycotoxins reported from *Aspergillus flavus* and its domesticated form *A. oryzae*MetaboliteReferenceCommentAflatoxins B~1~, B~2~, B~2α~, B~3~ and precursors\
Aflatoxins G~1~ and G~2~ have been found in few strains of *A. flavus* from South Korea.Hartley et al. ([@CR154]); Asao et al. ([@CR16]); van der Merwe et al. ([@CR471]); van Dorp et al. (1963); Asao et al. [@CR17]; Burkhart and Forgacs [@CR50]; Dutton and Heathcote ([@CR88]); Rodricks et al. ([@CR377]); Waiss et al. ([@CR484]); Heathcote and Dutton ([@CR162]); Holker et al. ([@CR170]); Cole et al. ([@CR74]); Schroeder and Kelton ([@CR404]); Frisvad et al. ([@CR104]); Rodríguez et al. ([@CR380])Only found in some strains of *Aspergillus flavus* and never found in *A. oryzae*Cyclopiazonic acid and iso-α-cyclopiazonic acid, β-cyclopiazonic acid (= bissecodehydrocyclopiazonic acid), α-cyclopiazonic acid imine, 2-oxocyclopiazonic acid, cyclopiamide A, cyclopiamide E & H, speradine A, B, C, D, E, F, H, I, 3-hydroxy-speradine A, cAATrp, and asperorydine A-MOhmomo et al. ([@CR331]) (misidentified as *A. versicolor*; Domsch et al. [@CR83]); Luk et al. ([@CR263]); Orth ([@CR333]); Gallagher et al. ([@CR120]); Tokuoda et al. ([@CR453]); Hu et al. ([@CR177],[@CR178]); Ma et al. ([@CR267]); Uka et al. ([@CR464]); Liu et al. ([@CR253])Cyclopiazonic acid has been found in several strains of both *A. flavus* and *A. oryzae*β-Nitropropionic acidBush et al. ([@CR53]); Nakamura and Shimoda ([@CR313]); Iwasaki and Kosikowski ([@CR187]); Orth ([@CR333]); He et al. ([@CR159])Found in some strains of both *A. oryzae* and *A. flavus*

*A. oryzae* is a domesticated species originating probably from *Aspergillus flavus*, and the two species can not be distinguished by DNA sequence differences. Since *A. oryzae* is domesticated, it can only be expected to be found in fermentation environments. Any *A. oryzae* recovered in nature can only be found there if it has escaped such a fermentation plant, and based on its adaptation to the fermentation environment, it must be expected to be a poor competitor in cereals, oilseeds, and nuts, where *A. flavus* is a very competitive species (Wicklow [@CR494]).

Aflatoxins {#Sec13}
----------

The aflatoxins (B~1~ and B~2~ primarily) are polyketides that have been found in many strains of *Aspergillus flavus*, albeit not the culture ex type of *A. flavus* (Varga et al. [@CR474]). Aflatoxin (AFL) has been reported from strains of *Aspergillus oryzae*, but these data are based on misidentified strains or misidentified mycotoxins or contaminated cultures (Varga et al. [@CR474]). It has been shown that strains of *Aspergillus oryzae* sensu stricto cannot produce AFL, as a result of the lack of essential parts of the gene cluster, e.g., deletion of the *aflR* gene involved in induction of biosynthesis (Cary and Ehrlich [@CR57]; Chang et al. [@CR62]; Lee et al. [@CR242],[@CR240]; Tominaga et al. [@CR455]; Takahashi et al. [@CR435], [@CR436]; Kiyota et al. [@CR211]; Hong et al. [@CR174]; Lee et al. [@CR239]; Tao and Chung [@CR447]). Therefore, AFL production can be excluded in *A. oryzae* sensu stricto. Furthermore, current industrial strains contain a deletion of the whole AFL gene cluster, providing additional safety in enzyme production. Type G aflatoxins (aflatoxin G~1~ and G~2~) have rarely been reported from *Aspergillus flavus*. In some cases, the G type aflatoxins were produced by *A. parasiticus* and other species from section *Flavi* (Varga et al. 2011), rather than isolates that confidently can be allocated to *A. flavus* sensu stricto. Saldan et al. ([@CR393]) reported on aflatoxin G~1~ production by *A. flavus* ATCC 9643, but this strain may not be an *A. flavus* sensu stricto. Five Korean strains of *A. flavus* sensu stricto were reported to produce the G-type aflatoxins (Frisvad et al. [@CR104]).

Cyclopiazonic acids {#Sec14}
-------------------

Cyclopiazonic acid (= α-cyclopiazonic acid) (CPA) is an indol tetrameric acid, hybrid polyketide/non-ribosomal peptide/DMAT (dimethylallyl terpene unit) compound that was isolated from *A. flavus* originally by Luk et al. ([@CR263]) and Gallagher et al. ([@CR120]) but has since been found repeatedly in *A. flavus* (Varga et al. [@CR475]). It was originally isolated from a fungus identified as *Penicillium cyclopium*, but the strains of *Penicillium*-producing cyclopiazonic acid were *Penicillium griseofulvum* and *Penicillium commune* (Frisvad [@CR102]; Frisvad et al. [@CR109]). CPA has also been isolated repeatedly from *Aspergillus oryzae* (Orth [@CR333]; Ohmomo et al. [@CR331], erroneously reported as *A. versicolor*; see Domsch et al. [@CR83]; Frisvad [@CR102]; Tokuoda et al. [@CR453]; Shaaban et al. [@CR409]). It is possible to remove the CPA gene cluster and thus avoid CPA production in biotechnological processes (Kato et al. [@CR202]). *A. oryzae* and *A. flavus* can produce a large number of secondary metabolites related to CPA including iso-α-cyclopiazonic acid, β-cyclopiazonic acid (= bissecodehydrocyclopiazonic acid), α-cyclopiazonic acid imine, 2-oxocyclopiazonic acid, cyclopiamide (A), cyclopiamide E & H, speradine A, B, C, D, E, F, H, I, 3-hydroxy-speradine A, cAATrp, and asperorydine A-M (Ohmomo et al. [@CR331]; Holzapfel et al. [@CR172]; Hu et al. [@CR177],[@CR178]; Ma et al. [@CR267]; Tokuoka et al. [@CR454]; Xu et al. [@CR499]; Uka et al. [@CR464]; Liu et al. [@CR253]) from *A. oryzae* and *A. flavus*, but speradine A is also produced by *Aspergillus tamarii* (Tsuda et al. [@CR457]). Some of the strains reported as *A. oryzae* producing these tetramic acids have been isolated from marine sources, so they may in fact be *A. flavus.* However, the speradines are related to CPA, produced by many strains of both *A. flavus* and *A. oryzae*, and so speradines are not unlikely secondary metabolites in *A. oryzae*. There have been some problems with the naming of speradine B that is a different speradine in *Penicillium dipodomyicola* (Wang et al. [@CR486]) than that from *A. flavus*, so some of the speradines need to be renamed.

β-nitropropionic acid {#Sec15}
---------------------

β-nitropropionic acid (BNP) is one of the real mycotoxins reported from authentic *Aspergillus oryzae* strains, but also from *A. flavus* strains (Bush et al. [@CR53]; Nakamura and Shimoda [@CR313]; Iwasaki and Kosikowski [@CR187]; Orth [@CR333]). It has caused sugarcane disease in children eating sugarcane infected with *Nigrospora* spp. that produce β-nitropropionic acid also (Liu et al. [@CR256]; Ming [@CR294]; Fu et al. [@CR111]; Johnson et al. [@CR195]; Fernagut et al. [@CR100]; He et al. [@CR161]). The genetic basis for production of BNP is not completely understood. Therefore, BNP levels are monitored in industrial enzyme productions.

Mycotoxins from *Trichoderma reesei* {#Sec16}
------------------------------------

It seems that chemotaxonomy is working excellently at the species level in *Trichoderma* (Kang et al. [@CR200]). In the latter paper, *T. reesei* was not included, and it is only few mycotoxins that are ascribed to *T. reesei* (Zeilinger et al. [@CR514]) (Table [4](#Tab4){ref-type="table"}). Reported mycotoxins from *T. reesei* (claimed to be a mutant of QM 9414 and called P-12) include trichodermin (Watts et al. [@CR490]), but this ability to produce trichodermin by *T. reesei* has been rejected by Nielsen et al. ([@CR319]). The latter authors claimed that only *Trichoderma brevicompactum* can produce trichodermin, and possibly also *Trichoderma arundinaceum* (Zeilinger et al. [@CR514]). There are also some trichothecene genes in *Trichoderma gamsii* and *Trichoderma asperellum*, but such genes have not been observed in *T. reesei* (Zeilinger et al. [@CR514]). Also, the mycotoxin gliotoxin has been mentioned as a potential secondary metabolite in *Trichoderma*, because a gene cluster seems to be present in the genome of this fungus (Zeilinger et al. [@CR514]). However, gliotoxin has never been detected in any culture of *T. reesei* (Martinez et al. [@CR277]; Kubicek and Druzhinina [@CR233]). *T. reesei* thus seems to be unable to produce mycotoxins.Table 4Mycotoxins reported from *Trichoderma reesei*MetaboliteReferenceCommentGliotoxinZeilinger et al. ([@CR514])Actual gliotoxin production was not shownTrichoderminWatts et al. ([@CR490]); Nielsen et al. ([@CR319])Culture could have been contaminated, but claimed to be derived from QM 9414 as strain P-12; the claim that *T. reesei* produces this mycotoxin may also be based on insufficient analytical chemical methods

Toxicity of fungal mycotoxins relevant for *A. niger*, *A. oryzae*, and *T. reesei* {#Sec17}
-----------------------------------------------------------------------------------

Mycotoxins often affect different vertebrate species very differently. However, to enable a comparison of the relative toxicity of the mycotoxins potentially produced by *A. niger*, *A. oryzae*, and *T. reesei*, an overview of acute oral toxicity is provided (Table [5](#Tab5){ref-type="table"}). In the enzyme industry, it is ensured that production strains based on *A. niger*, *A. oryzae*, and *T. reesei* do not produce mycotoxins when grown at large scale.Table 5Acute oral toxicity of mycotoxins potentially expressed by *Aspergillus niger*, *A. oryzae*, and *Trichoderma reesei*SpeciesMetaboliteLD50 (acute oral toxicity, mg/kg)ReferenceRatMouse*Aspergillus niger*Fumonisin B2\> 46.4^a^--McKean et al. ([@CR287])Fumonisin B4Fumonisin B6Oxalic acid375--Vernot et al. ([@CR479])Ochratoxin A2046Purchase and Theron ([@CR358])\
Kayoko ([@CR203])*Aspergillus oryzae*Cyclopiazonic acid3613Purchase ([@CR357]); Nishie et al. ([@CR323])ß-Nitropropionic acid6068Burdock et al. ([@CR49])\
Blumenthal et al. (2004)Kojic acid^b^18005100SCCS ([@CR401])^a^The listed value is for fumonisin B1 as the exact values for B2, B4, and B6 have not been determined^b^Kojic acid is not a mycotoxin and is included for comparison purposes only

As shown previously, *A. niger* can produce the mycotoxins ochratoxin A, fumonisins B~2~, B~4~, and B~6~, and oxalic acid, and *A. oryzae* can produce the mycotoxins cyclopiazonic acid and β-nitropropionic acid, and *T. reesei* has not been convincingly shown to produce any mycotoxins.

Improved safety of *A. oryzae* industrial strains {#Sec18}
-------------------------------------------------

As mentioned previously, *A. oryzae* strains are not able to produce aflatoxins due to the presence of disabling mutations in the gene cluster. Modern industrial strains have been developed that contain a large DNA deletion. This region includes the aflatoxin gene cluster and genes involved in the biosynthesis of cyclopiazonic acid (CPA, Christensen et al. [@CR69]). Thus, during industrial enzyme production using strains derived from A1560 containing the chromosomal deletion, the presence of neither aflatoxin nor CPA is a concern.

Secondary metabolite potential {#Sec19}
==============================

Fungal secondary metabolites are very diverse and include compounds with a wide range of applications (e.g., antibiotics, cancer treatment, immunosuppressing drugs, pigments, antioxidants).

Like many other fungi, *Aspergillus* species are capable of producing a very large number of drugs and drug-lead compounds. Among the best known for medical applications are the antibiotic penicillin to combat bacterial infections, the cholesterol-lowering mevinolin from *Aspergillus terreus*, the anticancer compound fumagillin from *Aspergillus fumigatus*, the antifungal echinocandin from *Aspergillus pachycristatus* and mulundocandin from *Aspergillus mulundensis* (Baltz et al. [@CR27]; Houbraken et al. [@CR176]; Zeiliger et al. [@CR515]; Bills et al. [@CR35]; Park et al. [@CR335]).

Fungi produce a large number of other secondary metabolites. Among them, fungal pigments such as polyketide-derived azaphilones are used to add color and as antioxidants in food. *Aspergillus* species are used to produce yellow and brown pigments like fumigatin (Hanson [@CR151]). Additionally, red pigments have been reported in, e.g., an *A. flavus* strain (Gurupavithra et al. [@CR143]). Carotenes are important terpenoid pigments and antioxidants that are produced in many bacteria, fungi, algae, and plants. Interestingly, carotene is produced by few *Aspergillus* species and not by *Trichoderma reesei* (Avalos and Limon [@CR21]).

Secondary metabolites described in *A. niger* {#Sec20}
---------------------------------------------

*Aspergillus niger* has been claimed to produce a very large number of secondary metabolites (Table [6](#Tab6){ref-type="table"}; Nielsen et al. [@CR321]) including isoflavones which are actually plant metabolites (Umezawa et al. [@CR469]; Nielsen et al. [@CR321]). Apart from many volatiles and small organic acids (Wani et al. [@CR488]; Priegnitz et al. [@CR355]; Costa et al. [@CR75]), *A. niger* sensu stricto can produce a variety of other secondary metabolites. In many cases, fungi identified as *A. niger* were indeed *A. tubingensis* or other closely related species (Table [2](#Tab2){ref-type="table"}).Table 6Secondary metabolites reported from *A. niger* and closely related speciesSecondary metaboliteReferenceCommentSmall acids: Glyoxylic acid, glycolic acid, hydropyruvic acid, parasorbic acid, sorbic acid, ascorbic acid, fumaric acid, gluconic acid, citric acid, glutaric acid, phenylacetic acid, phenoxyacetic acid, p-methoxyphenylacetic acid, 4-hydroxymandelic acid, D-galactonic acidNielsen et al. ([@CR321]); Cairns et al. ([@CR55])Anominine and other aflavininesFrisvad et al. ([@CR108])Found in sclerotia of *A. niger*Asperamide A & BZhang et al. ([@CR522],[@CR518],[@CR520],[@CR519])AsperenoneJefferson ([@CR192],[@CR193]); Yu et al. ([@CR511]); Pattenden ([@CR339], [@CR340]); Rabache et al. ([@CR362]); Rao et al. (2002)Also referred to as asperyellone and asperrubrolAspergetideLee et al. ([@CR241])AspergillinRay and Eakin ([@CR374])Aspernigrin A, B, C, DHiort et al. ([@CR169]); Ye et al. ([@CR508]); Zhou et al. ([@CR528])Azanigerones A-FZabala et al. ([@CR512])BicoumanigrinHiort et al. ([@CR169])Carlosic acid, agglomerin F, carlosic acid methyl esterYang et al. ([@CR504])Produced by *A. brasiliensis*ChlovalicinUchoa et al. ([@CR461])Identity of producer not convincingly confirmedCycloleucomelon and atromentinHiort et al. ([@CR169])Cyclo (trans-4-hydroxy-L-Pro-L-Leu), cyclo (L-Pro-L-Phe), cyclo (trans-4-hydroxy-L-Pro-L-Phe, Cyclo (L-Pro-L-Tyr), cyclo (L.Pro-L-val), cyclo (L-Pro-L-Leu)Uchoa et al. ([@CR461])Identity of producer not convincingly confirmedFunalenoneInokoshi et al. ([@CR183])Gibberellic acid, gibberellin, indoleacetic acidCihangir ([@CR70]); Ates et al. (2006); Lubna et al. ([@CR262])Producer is probably *A. tubingensis*JBIR-86 and JBIR-87Takagi et al. ([@CR434]); Henrikson et al. ([@CR163])Malformin A1, A2, B1, B2, B3, B5, CCurtis and Tanaka ([@CR76]); Yoshizawa et al. ([@CR510]); Sugawara et al. ([@CR425]); Kim et al. ([@CR205]); Zhou et al. ([@CR528]); Uchoa et al. ([@CR461])Kotanin, desmethylkotanin, orlandinCutler et al. ([@CR77]); Sørensen et al. ([@CR421]); Hüttel and Müller ([@CR181]); Girol et al. ([@CR133]); Mazzaferro et al. ([@CR284])MaltoryzinAbdelghany et al. ([@CR2])Identity of producer not convincingly confirmed4-Methoxybenzyl-7-phenylacetamido-3-vinyl-3-cephem-4-carboxylateBandara et al. ([@CR28])NafuredinUi et al. ([@CR463])Naphtho-γ-pyrones (asperpyrone A-E, aurasperone A-H, 10,10′-bifonsecin, 6'-O-demethylnigerone, 8'-O-demethylnigerone, 8'-O-demethylisomigerone, dianhydroaurasperone C, 6,9-dibromoflavasperone, flavasperone, fonsecin, fonsecine B = fonsecin monomethyl ether, fonsecinone A-D, 2-hydroxydihydronigerone, isoaurasperone A,F, isonigerone, nigerasperone A-C, nigerone, rubasperone A-G, rubrofusarin, rubrofusarin B = heminigerone, rubrofusarin-6-O-α-D-ribofuranoside, (R)-10-(3-succimidyl)-TMC-256A1, TMC-256A1, B1, C1, C2)Bouras et al. ([@CR41], [@CR42]); Lu et al. ([@CR260]); Choque et al. ([@CR67]); Happi et al. ([@CR152]); Li et al. ([@CR249]); Leutou et al. ([@CR244]); Li et al. ([@CR247]); Zhou et al. ([@CR528])Naphtho-γ-pyrones can be active against antibiotic resistant bacteria, have CNS repressant effects, inhibit Taq DNA polymerase, inhibit xanthine oxidase, inhibit acyl-CoA:cholesterol acyltransferase. Some produced only by *A. carbonarius* or *A. tubingensis*Nigerasterol A & BLiu et al. ([@CR255])Only produced by *A. tubingensis*Nigerazine A & BIwamoto et al. ([@CR186], [@CR185])The producer strain was probably a *A. tubingensis*NigerloxinRao et al. (2002); Sing et al. (2016)Identity of the producer strain is questionableNigragillin and aspernigerinCaesar et al. ([@CR54]); Alvi et al. (2000); Shen et al. ([@CR410]); Frisvad et al. ([@CR108]); Bandara et al. ([@CR28])Nygerone A and BHenrikson et al. ([@CR164])Penicillin/penicillin-likeFoster and Karow ([@CR101])Not yet confirmedPestalamide CBandara et al. ([@CR28])A tensidol"Product B"Lv et al. ([@CR265])Structure not knownProtocatechuic acidLv et al. ([@CR264])Small acidPseurotin A & DUchoa et al. ([@CR461])Identity of producer not convincingly confirmedPyranonigrin A-E, SHiort et al. ([@CR169]); Schlingmann et al. ([@CR402]); Miyake et al. ([@CR297]); Awakawa et al. ([@CR22])PyrophenBarnes et al. ([@CR30])The producer strain was probably an *A. tubingensis*Tensidol A and BFukuda et al. ([@CR114]); Henrikson et al. ([@CR163])Tensyuic acid A-FHasegawa et al. ([@CR155])Ustiloxin like cyclic ribosomal peptidesNagano et al. ([@CR309])Yanuthones (A-E, 22-deacetylyanuthone, 1-hydroxyyanuthone A-C)Bugni et al. ([@CR48]); Holm et al. ([@CR171]); Petersen et al. ([@CR345])

Asperazine and similar diketopiperazine heterodimers (Varoglu et al. [@CR476]; Li et al. [@CR248]) are not produced by *A. niger*, but consistently by *A. tubingensis*, *A. vadensis*, and *A. luchuensis* (Nielsen et al. [@CR321]; Varga et al. [@CR473]; Hong et al. 2013). However, such re-identifications from *A. niger* to *A. tubingensis* mean that co-occurrring metabolites are not necessarily produced by *A. niger*. For example, an asperazine- and asperazine A-producing isolate of *A. tubingensis* also produced cyclo(D-Phe-L-Trp), cyclo(L-Trp-L-Trp), walterolactone A, campyrones A-C, and kojic acid. According to our data, campyrones A-C are only produced by strains of *A. tubingensis*, and not by *A. niger* (but see Talontsi et al. [@CR437]). Varoglu and Crews ([@CR477]) reported on asperic acid, hexylitaconic acid, malformin C, and pyrophen production by an asperazine-producing fungus, which should also be identified as *A. tubingensis*. Several of these compounds have later been found in *A. tubingensis* including 2-methylene-3-(6-hydroxyhexyl)-butanedioic acid, 2-carboxymethyl-3-hexyl-maleic acid anhydride, 2-methylene-3-hexyl-butanedioic acid (Almassi et al. [@CR9]), demethylkotanin, TMC-256A1, TMC-256-C1 with an asperazine derivative (Ovenden et al. [@CR334]), ergosterimide, 5,7-dihydroxy-2-\[1-(4-methoxy-6-oxo-6H-pyran-2-yl)-2-phenylethylamino\]-\[1,4\]naphthoquinone, asperamide A & B, aspergillusol, asperpyrone A & C, dianhydroauransperone C, fonsecinone A-D, isopyrophen, nigerasperone A--C, aurasperone A--B, pyrophen, cyclo(L-Trp-L-Ile), cyclo(L-Trp-L-Phe), cyclo(L-trp-L-Tyr) (Zhang et al. [@CR522],[@CR518],[@CR520],[@CR519], [@CR517]) asperic acid, campyrone A & C, tubigenoid anhydride A, 2-carboxymethyl-3-hexylmaleic anhydride (Koch et al. [@CR222]), 6-isovaleryl-4-methoxy-pyran-2-one, asperpyrone A, campyrone A and rubrofusarin B (Ma et al. [@CR266]), nigerapyrone A-E and asnipyrone A & B, and nigerasterols (Liu et al. [@CR254], [@CR255]), and malformin A1, cyclo(Gly-L-Pro) and cyclo(Ala-Leu) (Tan et al. [@CR440]). Gibberellic acid reported from *A*. "*niger*" NRRL 2270 (Ates and Gökdere [@CR20]) is rather produced by *A. tubingensis* (this strain has indeed been reidentified as such) (Frisvad et al. [@CR107]). A strain of *Pestalotiopsis theae* was probably overgrown by a strain of *A. tubingensis*, and thus, further secondary metabolites from *A. tubingensis* include pastalazine A & B and pestalamide A--C together with asperazine, aspernigrin A, and carbonarone A (see Ding et al. [@CR81]).

A strain identified as *A. niger* was reported to produce asperiamide B and C (Wu et al. [@CR497]), but it also produces the aflatoxin precursors averufin and nidurufin, so this strain was probably an *A. flavus*.

Small acids of *Aspergillus niger* {#Sec21}
----------------------------------

Oxalic acid, gluconic acid, and citric acid are small chelating organic acids derived from the citric acid cycle, but since they are secreted and accumulated may be characterized as secondary metabolites (Poulsen et al. [@CR353]; Niu et al. [@CR326]). These are by far the small organic acids produced in the highest amounts, but other acids can be produced by *A. niger* (Table [5](#Tab5){ref-type="table"}).

Aflavinines {#Sec22}
-----------

Aflavinines are indoloterpenes biosynthesized from tryptophan and dimethylallyl units. They are only produced in sclerotia of *A. niger* (Frisvad et al. [@CR108]). Such sclerotia are not produced on ordinary laboratory media, except if they are induced by the presence of small dried fruits, such as raisins (Frisvad et al. [@CR108]). Most aflavinines are antiinsectan, but are not known to be toxic towards vertebrates (Gloer et al. [@CR134]).

Asperamides {#Sec23}
-----------

Asperamides are sphingolipids and unusual cerebrosides (Zhang et al. [@CR522],[@CR518],[@CR520],[@CR519]). Such sphingolipids appear to be pretty widespread in fungi, but their function in fungi is often unknown. The similar flavusides from *A. flavus* are antibacterial (Yang et al. [@CR505]).

Asperenones {#Sec24}
-----------

The terpenes asperenones, asperyellones, and asperrubrols are carotenoid-like secondary metabolites. Asperenone is a human platelet aggregation inhibitor, and a strain of *A. niger* has been optimized for higher production of this bioactive compound (Chidananda et al. [@CR66]).

Aspergitides {#Sec25}
------------

Aspergitides are NRP-derived tetrapeptides which are potentially anti-inflammatory (Lee et al. [@CR241]). These hydrophobic tetrapeptides have some similarity with fungisporins and nidulanins which appear to be generally present in *Aspergillus* and *Penicillium* species (Ali et al. [@CR8]; Klitgaard et al. [@CR217]; Hautbergue et al. [@CR158]).

Aspergillin {#Sec26}
-----------

Aspergillin is a green polyketide (Ray and Eakin [@CR374]) that may be connected with the production of the black pigment in the spores of *A. niger*. Other (yellow) pigments, such as funalenone and naphtho-γ-pyrones, are also connected with black melanin (Jørgensen et al. [@CR197]).

Aspernigrins {#Sec27}
------------

The aspernigrins, carbonarones, nygerones, pestalamides, pyrophen, and tensidols are all related 2-benzylpyridin-4-one-containing metabolites of non-ribosomal peptide (NRP) and polyketide origin. They have several effects such as inhibiting HIV virus, being antifungal, or having neuroprotective effects (Hiort et al. [@CR169]; Ye et al. [@CR508]; Ding et al. [@CR81], Bandara et al. [@CR28]; Zhou et al. [@CR528]). They have been isolated from *Aspergillus* section *Nigri* isolates and from fungi claimed to be *Cladosporium* (Ye et al. [@CR508]) and *Pestalotiopsis theae* (Ding et al. [@CR81]). The latter two fungi appear to have been overgrown by *Aspergillus niger* and *Aspergillus tubingensis*, respectively, as all secondary metabolites from these fungi have only been found in *Aspergillus* section *Nigri* (Nielsen et al. [@CR321]).

Azanigerones {#Sec28}
------------

The azanigerones A--F needed chromatin remodeling in order to be produced by *Aspergillus niger* (Zabala et al. [@CR512]). These compounds are polyketides, and little is known of their activity. However, like other azaphilones, they can probably bind amino acids, but no nitrogen-containing derivatives have been found yet.

Cycloleucomelone {#Sec29}
----------------

Cycloleucomelone, leucomelone, and atromentin are shikimic acid-derived secondary metabolites that have been found in basidiomycetes (Turner [@CR459]; Turner and Aldridge [@CR460]) but also species in *Aspergillus* section *Nigri* (Hiort et al. [@CR169]; Nielsen et al. [@CR321]). These types of compounds may have radiation-protective characteristics, and they are widespread in *Aspergillus* (Frisvad and Larsen [@CR105]). The analogous (heteroisoextrolites) terphenyllins are for example produced by members of *Aspergillus* section *Candidi* and aspulvinones by *Aspergillus* section *Terrei* (Turner [@CR459]; Turner and Aldridge [@CR460]; Frisvad and Larsen [@CR105]).

Funalenone and naphtho-γ-pyrones {#Sec30}
--------------------------------

These polyketides have some genes in common with the pksA gene for production of the black pigment in *Aspergillus niger* (Jørgensen et al. [@CR197]). Some naphtho-γ-pyrones have been claimed to be toxic (Ghosal et al. [@CR128]), but they are not mycotoxins according to the definition accepted here. In fact, they can be exploited industrially as they have anti-oxidant, anti-cancer, anti-microbial, anti-HIV, anti-hyperuricuric, and anti-tubercular effects (Choque et al. [@CR67]).

Malformins {#Sec31}
----------

Malformins are NRP cyclic peptides that originally were cited as toxic (Anderegg et al. [@CR12]; Kobbe et al. [@CR221]; Cole and Cox [@CR72]), but they are not within the definition of mycotoxins in a strict sense, as malformin A has an oral LD~50~ of more than 50 mg/kg body weight in male mice. The toxicity data of Anderegg et al. ([@CR12]) and Kobbe et al. ([@CR221]) were based on malformin injection, which is not a natural route of intake. Furthermore, malformins have never been detected after mycotoxicosis caused by *A. niger*. Malformins are very promising anti-cancer agents, however (Park et al. [@CR336]).

Nafuredin {#Sec32}
---------

Nafuredin is a polyketide terpene-derived secondary metabolite and is an inhibitor of anaerobic electron transport in pig roundworm, but it has very low effect on mammalian enzymes (Ui et al. [@CR463]). It is a promising antihelminthic drug lead candidate.

Nigerasterols {#Sec33}
-------------

Nigerasterols are terpene-derived sterols that display potent activity against tumor cell lines (Liu et al. [@CR255]). There are as yet no data on vertebrate toxicity. The fungus (MA-132) was identified only by using ITS sequences, so it may be another species in *Aspergillus* section *Nigri* than *A. niger* that produces nigerasterols.

Nigerazines, aspernigerin, and nigragillins {#Sec34}
-------------------------------------------

The nigerazines, nigragillins, and aspernigerin are all related NRP-derived secondary metabolites. They are weakly insecticidal, and nigerazine B inhibits the root growth of lettuce seedlings (Caesar et al. [@CR54]; Iwamoto et al. [@CR186]). They have not been reported as mycotoxins.

Nigerloxin {#Sec35}
----------

Nigerloxin is derived from an inhibitor of soy bean lipoxygenase and rat lens aldose reductase (Rao et al. [@CR369],[@CR370]). It is a polyketide NRP hybrid. It is a strong antioxidant and is anti-diabetic and of low toxicity (Rao et al. [@CR371]; Suresha and Srinivasan [@CR430]; Vasantha et al. [@CR478]).

Pseurotins {#Sec36}
----------

Pseurotins are NRP polyketide hybrid secondary metabolites that have neuritogenic (Komagata et al. [@CR227]), antibiotic (Mehedi et al. [@CR290]; Pinheiro et al. [@CR347]), anti-inflammatory (Shi et al. [@CR411]), chitin-synthase inhibitor (Wenke et al. [@CR491]), and antileishmanial and anticancer (Martinez-Luis et al. [@CR278]) characteristics. Pseurotin A & D was reported to be produced together with chlovalicin (Uchoa et al. [@CR461]) probably coded by an intertwined gene clusters, as is the case for *Aspergillus fumigatus*, where pseurotin A and fumagillin, chemically closely related to chlovalicin, are coded by an intertwined gene cluster (Wiemann et al. [@CR496]; Kishimoto et al. [@CR209]). However, psurotins have not been reported from any other isolate of *A. niger* (Nielsen et al. [@CR321]), so the two metabolites may be produced by another species in *Aspergillus* section *Nigri*.

Pyranonigrins {#Sec37}
-------------

The pyranonigrins A--K are NRP-PK derived antioxidant secondary metabolites from *A. niger* (Hiort et al. [@CR169]; Miyake et al. [@CR296]; Kishimoto et al. [@CR209]). There are several pyranonigrins isolated from *Aspergillus niger*, including pyranonigrin A--K (Kishimoto et al. [@CR209]).

TAN-1612 {#Sec38}
--------

The polyketide tetracyclic compound TAN-1612=BMS-192548 has been isolates from *Aspergillus tubingensis* WB 2346 and *A. niger* ATCC 1015 (Li et al. [@CR246]). It is a neuropeptide Y receptor and neurokinin-1 receptor inhibitor (Kodukula et al. [@CR224]; Shu et al. [@CR418]).

Tensyuic acids {#Sec39}
--------------

The tensyuic acids are itaconic acid-derived secondary metabolites with anti-protozoan and antibacterial activities (Hasegawa et al. [@CR155]; Matsumara et al. [@CR281]).

Yanuthones {#Sec40}
----------

The yanuthones are meroterpenoids with a 6-methyl salicylic acid precursor and terpene units attached (Holm et al. [@CR171]; Petersen et al. [@CR345]; Nielsen et al. [@CR320]). There are no toxicity data for yanuthones, but they have antifungal activity (Petersen et al. [@CR345]).

Secondary metabolites described in *A. oryzae* and *A. flavus* {#Sec41}
--------------------------------------------------------------

*A. flavus* and *A. oryzae* can produce many secondary metabolites (Table [7](#Tab7){ref-type="table"}). These can be subdivided into biosynthetic families. It is very interesting to note that, e.g., ustiloxin B and ustilaginoidin C, have both been isolated from the rice false smut pathogen *Villosiclava virens* (= *Ustilaginoidea virens*) even though they are not biosynthetically related. However, these two types of secondary metabolites have also been found in *Aspergillus flavus* (Umemura et al. [@CR468]; Tsukui et al. [@CR458]; Yoshimi et al. [@CR509]). This is remarkable as both unrelated fungi occur on rice. One speculation could be that the gene clusters for both ustiloxins and ustilaginoidins were horizontally transferred from one fungus to the other during evolution. Ustilaginoidins are bis-naphtho-γ-pyrones (even called "mycotoxins" in the paper of Meng et al. [@CR291] and ustiloxins for toxic cyclic peptides by Tsukui et al. [@CR458]). Like the heteroisoextrolite (Frisvad and Larsen [@CR105]) analogues in *Aspergillus* section *Nigri* (normally also called naphtho-γ-pyrones, Nielsen et al. [@CR321]; Lu et al. [@CR260]; Choque et al. [@CR67]), the ustilaginoidins are probably also involved in the formation of the green conidium color of *Aspergillus* section *Flavi* as it is known for the involvement of naphtho-γ-pyrones in black pigmentation in *Aspergillus* section *Nigri* isolates (Chiang et al. [@CR65]; Jørgensen et al. [@CR197]; Frisvad et al. [@CR108]; Niu et al. [@CR326]). Other important secondary metabolites are described subsequently. Additionally, secondary metabolites that have been erroneously assigned to *A. flavus* or *A. oryzae* are also listed (Table [8](#Tab8){ref-type="table"}).Table 7Primary and secondary metabolites reported from *Aspergillus flavus* and its domesticated form *A. oryzae* apart from aflatoxins and CPA-related compoundsMetaboliteReferenceCommentAntioxidants: γ-tocopherol, d-tocopherol, genistin, daizein, genistein and 3-hydroxyanthranilic acidEsaki et al. ([@CR96]); Matsuo ([@CR282])These are plant metabolites from *Glycine max* (soya) and not produced by the fungus, however the vitamins (tocopherols) could also be produced by *A. flavus* and *A. oryzae*Asperfuran (= arthrographol)Pfefferle et al. ([@CR346]); Ayer and Nozawa ([@CR23])Aspergillic acidWhite and Hill ([@CR493]); Dutcher ([@CR86]); Dunn et al. ([@CR84]); Hummel, [@CR179]; Nakamura [@CR311]; MacDonald ([@CR268]) ;Assante et al. ([@CR18]); Lebar et al. (2018); Saldan et al. ([@CR393])Aspergillic acids are strong iron chelators (Assante et al. [@CR18]), and not produced by *A. oryzae*, but by *A. flavus*Aspergillomarasmin and anhydromarasmic acidPlattner and Clauson-Kaas ([@CR349]); Hardegger et al. ([@CR153]); Haenni et al. ([@CR144]; [@CR145]); Robert et al. ([@CR376]); Lallouette ([@CR235]); Lederer ([@CR237])The related phytotoxin lycomarasmin is produced by *Fusarium* speciesAsperopterin A & BMatsuura et al. ([@CR283])Nucleobase derivedAspirochlorin = oryzachlorin, dechloroaspirochlorine and O,O-dimethylaspirochlorine, trithioaspirochlorineKato et al. ([@CR201]); Berg et al. ([@CR33]); Sakata et al. ([@CR391], [@CR389], 1987,b); Klausmeyer et al. ([@CR213]); Rank et al. ([@CR368]); Chankhamjon et al. ([@CR63])Original production strains classified as *A. tamarii*, *A. oryzae* and *A. flavus*BiotinFukui et al. ([@CR115],[@CR116])VitamineBromoaspirochlorineSakata et al. ([@CR390],[@CR392])Aspirochlorin biosynthetic family of compoundsCanadensolideSakata et al. ([@CR391])Citric acidSakaguchi et al. ([@CR386])While *A. niger* can accumulate large amounts of citric acid, *A. flavus* only produce low amountsDrim-9(11)-en-8-ol (R and S)Wada et al. ([@CR483]); Leite et al. ([@CR243]); Domínguez et al. (1991); Shishido et al. ([@CR417]); Armstrong et al. ([@CR14]); Jansen and de Groot (1991; 2004)Flufuran, 5-(hydroxymethyl)-2-furancarboxylic acid, vanillic acid, 2-furanol, 2-(4.hydrophenyl)-ethanol, 3,4-dihydroxybenzoic acidEvidente et al. ([@CR97]); Saldan et al. ([@CR393])Fumaric acidSakaguchi et al. ([@CR386])Small acid*l*-Glutamic acidKinoshita et al. ([@CR208])Amino acidHeptelidic acid (= koningic acid), gliocladic acid, trichoderonic acid, hydroheptelidic acidLee et al. ([@CR238]); Skóra et al. ([@CR419]); Nishimura et al. ([@CR325])InositolFukui et al. ([@CR115],[@CR116])Sugar alcoholα-Ketoglutaric acidSakaguchi et al. ([@CR386])Small acidKojic acid, methyl kojic acid, dimethyl kojic acidSaito ([@CR383]); Yabuta ([@CR501]); Tamiya ([@CR438]); Birkinshaw et al. ([@CR36]); Jennings and Williams ([@CR194]); Parrish et al. ([@CR337]); Morton et al. ([@CR303]); Marston ([@CR276]); Kistner ([@CR210]); Bentley ([@CR32]); Yang et al. ([@CR505])Production strains classified as *A. effusus*, *A. luteovirescens* or *A. lutescens*Kojic acid-2 (BGY-F)Zeringue et al. ([@CR516])Bright green flourescent moleculeKojistatin A = CPI-4, CPI 1--3, CPI 5Sato et al. ([@CR400]); Yamada et al. ([@CR502])Lactic acidSakaguchi et al. ([@CR386])Small acid*l*-Malic acidSakaguchi et al. ([@CR386]); Abe et al. ([@CR4])Small acidOrange-red pigmentManonmani and Sreektaniah ([@CR273])Unknown structureOryzacidinShimoda ([@CR414])C~8~H~13~O~5~N, an antibioticOryzachlorin = Aspirochlorine = A 30641Kato et al. ([@CR201])See AspirochlorinPantothenic acidFukui et al. ([@CR115],[@CR116])VitaminePenicillin*A. oryzae*: Waksman and Bugie ([@CR485]); Foster and Karow ([@CR101]); Marui et al. ([@CR279])\
*A. flavus*: White ([@CR492]); Bush and Goth ([@CR51]); McKee and MacPhillamy ([@CR288]); McKee et al. ([@CR289]); Waksman and Bugie ([@CR485]); Bush et al. ([@CR52]); Dey ([@CR79]); Adler and Wintersteiner ([@CR6]); Guida ([@CR142])PyrodoxineFukui et al. ([@CR115],[@CR116])VitamineRiboflavinPontovich ([@CR351]); Zalesskaya et al. ([@CR513]); Mogi et al. ([@CR300]); Higuchi ([@CR168])VitamineSporogene AO1Tanaka et al. ([@CR444],[@CR445]); Tamogami et al. ([@CR439])Succinic acidSrinisavan and Ramakrishnan ([@CR423]); Sakaguchi et al. ([@CR386])Small acidThiamineFukui et al. ([@CR115],[@CR116])VitamineUstilaginoidin CBrown et al. ([@CR45])Conidium pigmentViolacetinKobayashi ([@CR218])Probably a mistake, most likely originated from a contaminating ActinomyceteVitamine B~12~ (cyanocobalamine) and K3Sakai ([@CR387]); Ramakrishnan and Sathe ([@CR55])Vitamine, production strain *A. oryzae* var. *microsporus*Ustiloxin BUmemura et al. (2013); Nagano et al. ([@CR309]); Ye et al. ([@CR507]); Yoshimi et al. ([@CR509])No production in *A. oryzae* RIB40Table 8Secondary metabolites *erroneously* ascribed to *Aspergillus flavus* or *A. oryzae*MetaboliteReferenceCommentAflatoxins in *A. oryzae*El-Hag and Morse ([@CR90]) (see Fennell, [@CR99]); El-Kady et al. ([@CR91]); Atalla et al. ([@CR19])Aflatoxin production reported from NRRL 1988 was refuted by Fennell ([@CR99]). The culture was a mixed culture with a strain of *Aspergillus parasiticus*. Later reports on aflatoxin production by *A. oryzae* were erroneous (Varga et al. [@CR474])Aflatoxin G1 in *A. flavus*Saldan et al. ([@CR393])Aflatoxin G~1~ has only been found very rarely in *A. flavus* but has been found more often in other species in section *Flavi* (Frisvad et al. [@CR104])Asperaculin ASon et al. ([@CR420])Identity of strain (KCCM 12698) and compound dubious, compound only tentatively assignedAsperentin = cladosporin, asperentin 8-O-methylether, asperentin 6-O-methyl ether, 5′-hydroasperentinGrove (1972a, [@CR140])Producer strain is *A. pseudoglaucus* (Chen et al. [@CR64])Asperflavin, anhydroasperflasvin, 5,7-dihydroxy-4-methylphthalideGrove ([@CR139])Producer strain is *A. pseudoglaucus* (Chen et al. [@CR64])Asporyzin A, B and CQiao et al. ([@CR359]); Nozawa et al. ([@CR328]); Kimura et al. ([@CR206])Producer strain is *A. niveus*, *A. cejpii* or *A. striatus*Austalide F & HSon et al. ([@CR420])Identity of strain and compound dubious, compounds tentatively assignedAspyroneSaldan et al. ([@CR393])Identity of strain and compound dubiousBetaineSaldan et al. ([@CR393])Identity of strain and compound dubiousChrysogineSaldan et al. ([@CR393])Chrysogine has not been found in *A. flavus*, but in other members of *Aspergillus* section *Flavi* (Frisvad et al. [@CR104])CyclopenolZhuravleva et al. ([@CR529])Producer strain was probably *Aspergillus amoenus*Deacetoxyscirpenol (DON)Rahssaparpoor ([@CR363])Misidentification of compound. Producer strain was claimed to be *A. flavus*Deacetylparasiticolide ASaldan et al. ([@CR393])Identity of strain and compound dubious, parasiticolides have not been found in *A. flavus*, but in other members of *Aspergillus* section *Flavi* (Frisvad et al. 2018)Decumbenone BZhuravleva et al. ([@CR529])Producer strain is probably *Aspergillus amoenus*5,7-Dihydroxy-4-methylisobenzofuran-1-(3H)-oneGrove ([@CR138],[@CR139]); Kobayashi et al. ([@CR220])*A. pseudoglaucus* is the actual producer of this compoundDihydroxymethoxycoumarin & ketone-citreoisocoumarinSon et al. ([@CR420])Identity of strain and compound dubious; compound tentatively assignedEmindole SBQiao et al. ([@CR359]); Nozawa et al. ([@CR328]); Kimura et al. ([@CR206])Producer strain is *A. niveus*, *A. cejpii* or *A. striatus*EmeniveolQiao et al. ([@CR359]); Nozawa et al. ([@CR328]); Kimura et al. ([@CR206])Producer strain is *A. niveus*, *A. cejpii* or *A. striatus*GliotoxinLewis et al. ([@CR245]); Kupfahl et al. ([@CR234])Data not substantiated (Patron et al. ([@CR338]); Manzanares-Miralles (2016); Vidal-Garcia et al. ([@CR481])Gregatin BSaldan et al. ([@CR393])Identity of strain and compound dubiousHexylitaconic acidSon et al. ([@CR420])Identity of strain and compound dubious; compound tentatively assigned by MS4-hydroxy-asperentin, 5′-hydroxyasperentin 8-methyl etherGrove ([@CR141])*A. pseudoglaucus* is the actual producer of this compoundHydroxysydonic acidSaldan et al. ([@CR393])Identity of strain and compound dubiousIsoflavipucineMituzani et al. ([@CR295])Producer strain is *A. flavipes*, not *A. flavus*JBIR-03Qiao et al. ([@CR359]); Nozawa et al. ([@CR328]); Kimura et al. ([@CR206])Producer strain is *A. niveus*, *A. cejpii* or *A. striatus*Kipukacin JZhuravleva et al. ([@CR529])Producer strain is *Aspergillus amoenus*MaltoryzinIizuka and Iida ([@CR182]); Bakhali et al. (2013)Assigned to *A. flavus* var. *microsporis* but the producer strain is probably *A. clavatus* (Varga et al. [@CR472])Mycophenolic acidKobayashi et al. ([@CR220])*A. pseudoglaucus* is the actual producer of this compound (Chen et al. [@CR64])Nicotinic acidSaldan et al. ([@CR393])Identity of strain and compound dubiousNivalenol, deoxynivalenol, T-2 toxinElsahrkawy and Abbas, [@CR93]; Atalla et al. ([@CR19])Apparently both fungus and mycotoxin were misidentified in this work, the substrate was contaminated, or the trichotecenes were biotransformed (also the case for *A. niger*)Ochratoxin A and BAtalla et al. ([@CR19])Apparently both fungus and mycotoxin were misidentified in this workPentahydroxy-anthraquinoneSon et al. ([@CR420])Identity of strain and compound dubious; compound tentatively assignedOmoflavipucineMituzani et al. ([@CR295])Producer strain is *A. flavipes*, not *A. flavus*Phomaligin ASaldan et al. ([@CR393])Identity of strain and compound dubiousSpinulosinSaldan et al. ([@CR393])Identity of strain and compound dubiousSterigmatocystin in *A. oryzae*Atalla et al. ([@CR19])Apparently both fungus and mycotoxin were misidentified in this work(3S,6S)-Terramide A and BGarson et al. ([@CR124])Listed as being produced also by *A. flavus*, in addition to *A. terreus* in AntiBase, no references could be found to the possible fact that *A. flavus* can produce terramidesTerreinSaldan et al. ([@CR393])Identity of strain and compound dubiousTaxolEl-Sayed et al. ([@CR94])Both producer and secondary metabolite production needs to be verifiedViolacetinKobayashi ([@CR218]); Aiso et al. ([@CR7])Violacetin is a *Streptomyces* secondary metabolite, not of fungal originZearalenoneAtalla et al. ([@CR19])Apparently both fungus and mycotoxin were misidentified in this work

Aflatrems {#Sec42}
---------

Aflatrem and β-aflatrem and their precursors are indoloterpenes that have been found in sclerotia of *Aspergillus flavus* (Gallagher and Wilson [@CR121]; Gallagher et al. [@CR118],[@CR119]; Valdes et al. [@CR470]; Tanaka et al. [@CR443]; TePaske et al. [@CR450]; Zhang et al. [@CR521]; Duran et al. [@CR85]; Nicholson et al. [@CR318]; Ehrlich and Mack [@CR89]; Tang et al. [@CR446]; Gilbert et al. [@CR131]). *Aspergillus oryzae* RIB 40 was found to produce the 13-desoxypaxilline precursor to aflatrem (Rank et al. [@CR368]), and aflatrem has been heterologously expressed in *A. oryzae* NSAR1 (Tagami et al. [@CR433]). However, if RIB40 is indeed a real *A. flavus*, *A. oryzae* sensu stricto isolates are not be able to produce sclerotia and sclerotial metabolites such as aflatrem.

Aflavarins {#Sec43}
----------

Aflavarins are polyketides found in the sclerotia of *Aspergillus flavus* (TePaske et al. [@CR450]). These polyketides have not yet been found in any *A. oryzae* strain. Leporins, also found in *A. leporis* (TePaske et al. [@CR449]), have been found in *A. flavus* (Cary et al. [@CR58]), but they are not expected to be produced by *A. oryzae*.

Aflavinins {#Sec44}
----------

The aflavinins are sclerotium-borne indoloterpenes first isolated from *A. flavus* (Gallagher et al. [@CR118],[@CR119]; Cole et al. [@CR73]; Wicklow and Cole [@CR495]; Gloer et al. [@CR134]). These indoloterpenes and aflavazol were also isolated from the sclerotia of *A. oryzae* RIB40 (TePaske et al. [@CR448]; Rank et al. [@CR368]). The aflavinins isolated from *A. flavus* (possibly *A. minisclerotigenes* or *A. aflatoxiformans*) include aflavinine, dihydroxyaflavinine, monohydroxyaflavinine, and monohydroxyisoaflavinine (Nozawa et al. [@CR329]; Tang et al. [@CR446]).

Asperfuran {#Sec45}
----------

Asperfuran is a dihydrobenzofuran compound that was isolated from *Aspergillus oryzae* "HA 302-84" (Pfefferle et al. [@CR346]), but it has also been isolated under the name of arthrographol from *Arthrographis pinicola* (Ayer and Nozawa [@CR23]) and as asperfuran from *Penicillium* species (Yamaji et al. [@CR503]; Frisvad et al. [@CR109], [@CR106]). Asperfuran is antifungal, but there are no reports on toxicity of this compound. Asperfuran production by authentic strains of *A. oryzae* has later been confirmed, and it has also been detected in *Aspergillus sojae* (Varga et al. [@CR475]).

Aspergillic acids {#Sec46}
-----------------

These iron-chelating compounds have been used for discrimination between *A. flavus* and *A. oryzae*, in that *Aspergillus oryzae* sensu stricto has been claimed not to produce any of these pyrazine compounds. Testing *Aspergillus flavus* sensu stricto and *Aspergillus oryzae* sensu stricto has shown that it is only the former that can produce aspergillic acids (Bothast and Fennell [@CR40]; Hamsa and Ayres [@CR147]; Pitt et al. [@CR348]; Assante et al. [@CR18]; Liljegren et al. [@CR250]; Varga et al. [@CR475]). However, compounds in this class have been reported from *A. oryzae*, including mutaaspergillic acid (Nakamura and Shiro [@CR314],[@CR315]; Nakamura [@CR312]; Sugiyama et al. [@CR427]; Ohta and Ohta [@CR332]), hydroxyaspergillic acid (Nakamura and Shiro [@CR314],[@CR315]; Dutcher [@CR87] (as *A. flavus*); MacDonald [@CR269]; Ohta and Ohta [@CR332]; Sano et al. [@CR398]), VI-2 (Ueno et al. [@CR462]), A-2 (Sano et al. [@CR398]), and aspergillic acid (Nishimura et al. [@CR324]). Aspergillic acids have been evaluated for toxicity (Sasaki et al. [@CR399]; MacDonald [@CR270]; Perry et al. [@CR344]), but Sano et al. ([@CR398]) suggest that the toxicity of aspergillic acids is so low that it can be present in fermented foods used for consumption. The strains producing aspergillic acid, indicated by the medium AFPA (*Aspergillus flavus parasiticus* agar), are probably representing *Aspergillus flavus* sensu stricto, but because of issues with potential aflatoxin production, they are called *A. oryzae* "short stipes." The indicative red-orange color is caused by reaction of ferric ions with aspergillic acids (Assante et al. [@CR18]) with none of these strains have been reported to produce aflatoxins (Sano et al. [@CR398]).

Aspergillomarasmins {#Sec47}
-------------------

Aspergillomarasmin A, anhydroaspergillomarasmin A, and anhydromarasmic acid are polyamino acid compounds/phytotoxins related to lycomarasmin from *Fusarium* (Plattner and Clauson-Kaas [@CR349]; Hardegger et al. [@CR153]), but they have also been found in *Aspergillus oryzae* or *A. flavus* (*A.* "*flavus oryzae*") (Haenni et al. 1962; Haenni et al. [@CR145]; Robert et al. [@CR376]). Aspergillomarasmin A is very interesting as it inhibits metallo-beta-lactamases and could thus help in overcoming bacterial resistance to penicillin (King et al. [@CR207]; Koteva et al. [@CR228]). There are no data of toxicity of these compounds yet.

Asperopterins {#Sec48}
-------------

Asperopterin A and B are compounds containing a pteridin ring system that were isolated from *Aspergillus oryzae* "T-17" (Kaneko and Sanada [@CR199]; Matsuura et al. [@CR283]; Hanaka et al. [@CR149]) and have since been synthesized (Sugimoto et al. [@CR426]; Hanaka and Yamamoto [@CR150]). Unfortunately, the original producer strain is not available, and there are no toxicity data available for the asperopterins. These compounds are blue fluorescing, so if they are produced by *A. oryzae* sensu stricto, these may be the compounds that could have been erroneously detected and identified as aflatoxins.

Aspirochlorines {#Sec49}
---------------

Aspirochlorine is a halogenated diketopiperazine with a central disulfide bridge that was first isolated from *Aspergillus oryzae* IAM-2613 under the name oryzachlorin (Kato et al. [@CR201]). The compound has also been chemically synthesized (Miknis and Williams [@CR292]; Wu et al. [@CR498]). However, oryzachlorin was later shown to be the same as aspirochlorine and A30641 (Sakata et al. [@CR391], [@CR389], [@CR390], [@CR292]). It was isolated under the name A30641 from *Aspergillus tamarii* NRRL 8101, where it was co-occurring with canadensolide (Berg et al. [@CR33]), as was also the case of a strain identified as *A. flavus* (Sakata et al. [@CR391]). A strain of the latter was not available for more detailed studies. Another strain identified as *A. flavus* ("MDH-1420") was shown to produce aspirochlorin and the related compound tetrathioaspirochlorine, and evidence for presence of the trithio analogue also (Klausmeyer et al. [@CR213]). Furthermore, a bromoaspirochlorin, dechloroaspirochlorine, and O,O-dimethylaspirochlorine have been reported (Sakata et al. 1987). Aspirochlorin has been shown to be a highly selective and potent inhibitor of protein synthesis (Monti et al. [@CR302]) and an effective inhibitor of fungi, bacteria, viruses, and murine tumor cells (Monti et al. [@CR302]; Chankhamjon et al. [@CR63]). For these reasons and because epipolythiodiketopiperazines are generally toxic, the latter authors called aspirochlorin for a mycotoxin. The related mycotoxin gliotoxin was reported from 4 and 13% of clinical *Aspergillus flavus* strains (Lewis et al. [@CR245]; Kupfahl et al. [@CR234]), but there is some doubt whether these data are correct (Patron et al. [@CR338]; Manzanares-Miralles et al. [@CR275]; Vidal-Garcia et al. [@CR481]). On the other hand, Shaaban et al. ([@CR409]) isolated the reduced form of gliotoxin from *A*. "*oryzae*" MMAO1, and this latter isolate could be *Aspergillus flavus* sensu stricto. Gliotoxin-producing isolates have not been available for the scientific community (Varga et al. [@CR475]). Aspirochlorin is a product of many species in section *Flavi*: *A. avenaceus*, *A. caelatus*, *A. oryzae*, *A. parvisclerotigenus*, *A. sojae*, and *A. tamarii* (Varga et al. [@CR475]).

Asporyergosterol {#Sec50}
----------------

Asporyergosterol and several other sterols were isolated from isolated from *Aspergillus oryzae* "cf-2" = CCTCC M 2010045, isolated from a marine alga (Qiao et al. [@CR360]). The strain isolated could equally well be another *Aspergillus*, as *A. oryzae* in principle cannot be isolated from natural sources. An oxylipin and several sterols were isolated from *A. flavus*, isolated from an alga by the same authors (Qiao et al. [@CR361]). The isolate also produced emeniveol and similar compounds and could probably in reality be *A. cejpii*, *A. niveus*, or *A. striatus*.

Avenaciolides and canadensolides {#Sec51}
--------------------------------

Canadensolides are formed via condensation of an acetate derived chain with a TCA cycle intermediate (Brookes et al. [@CR44]; Turner [@CR459]; Tanabe et al. [@CR441]). It was first isolated from "*Penicillium*" *canadense* (McCorkindale et al. [@CR285]), but it has been reported once from *A. flavus* (Sakata et al. [@CR391]), and the related avenaciolide has been reported from *A. avenaceus* in *Aspergillus* section *Flavi* (Brookes et al. [@CR44]; Tanabem et al. [@CR441]; Varga et al. [@CR475]). The avenaciolides are also present in *Aspergillus glaber* and *A. stramenius* from *Aspergillus* section *Fumigati* (Ellis et al. [@CR92]; Samson et al. [@CR394]), and the avenaciolides are active against methicillin-resistant Staphylococci (Chang et al. [@CR61]). Avenaciolide is also a specific inhibitor of glutamate transport in rat liver mitochondria (McGivan and Chappell [@CR286]). Isoavenaciolide has been reported as an anti-cancer agent (Al-Tel et al. [@CR11]). However, there are no indications that avenaciolide is a mycotoxin.

Csypyrones {#Sec52}
----------

Type III polyketides are rare among fungi, but more common in plants and bacteria (Juvvadi et al. [@CR198]; Hashimoto et al. [@CR156]; Shimizu et al. [@CR413]). *Aspergillus oryzae* can, however, produce csypyrone B1, B2, and B3 and 3,5-dihydroxybenzoic acid (Seshime et al. [@CR406], [@CR408],[@CR407]; Hashimoto et al. [@CR157]). Interestingly, *Aspergillus niger* produces protocatechuic acid, also a type III polyketide (Lv et al. [@CR264]). Other fungi that can produce type III polyketides are and *Botrytis cinerea* (Hashimoto et al. [@CR156]). There are no toxicity data for these secondary metabolites.

Drim-9(11)-en-8-ol (R and S) {#Sec53}
----------------------------

This sesquiterpene compound has been isolated from *A. oryzae* strains that also produce sporogen AO1 and similar compounds, but very little is known on the bioactivity of this compound (Wada et al. [@CR483]; Leite et al. [@CR243]; Domíngues et al. [@CR82]; Shishido et al. [@CR417]; Armstrong et al. [@CR14]; Jansen and de Groot [@CR189]; [@CR190]).

Flufuran {#Sec54}
--------

Flufuran, other related furans, and small molecular weight secondary metabolites, including 4-hydroxybenzoic acid, were isolated from *Aspergillus oryzae* and *A. flavus* (Evidente et al. [@CR97]; Lee et al. [@CR238]; Saldan et al. [@CR393]). Flufuran has antifungal activity (Evidente et al. [@CR97]).

Heptelidic acids {#Sec55}
----------------

Heptelidic acid (=koningic acid), hydroheptelidic acid, gliocladic acid, and trichoderonic acid are sesquiterpenes that have antibiotic and anticancer properties (Itoh et al. [@CR184]; Nakazawa et al. [@CR317]; Kim and Lee [@CR204]). Heptelidic acid has been reported from both *Aspergillus oryzae* and *A. flavus* (Lee et al. [@CR238]; Skóra et al. [@CR419]).

Kojic acids {#Sec56}
-----------

Kojic acid was the first compound to be isolated from *Aspergillus oryzae* (Yabuta [@CR500], [@CR501]; Birkinshaw et al. [@CR36]; Jennings and Williams [@CR194]; Parrish et al. [@CR337]; Morton et al. [@CR303]; Marston [@CR276]; Bentley [@CR32]). A dimer of kojic acid has been structure-elucidated as the bright greenish yellow flourescence pigment from *Aspergillus flavus* (Zeringue et al. [@CR516]). Koji acid is common for nearly all species in *Aspergillus* section *Flavi* (Varga et al. [@CR475]). However, kojic acid is not regarded as a mycotoxin (Bentley [@CR32]). The gene cluster coding for kojic acid production is known (Terabayashi et al. [@CR451]). 7-O-acetylkojic acid has also been isolated from *A. flavus* (Sun et al. [@CR429]).

Kojistatins {#Sec57}
-----------

An isolate of an industrial strain of *Aspergillus oryzae* (ATCC 20386 and FERM-15834) produced kojistatin A = CPI-4 and related cystein protease inhibitors, called CPI 1-5 (Sato et al. [@CR400]; Yamada et al. [@CR502]). The kojistatins are nonribosomal peptide--polyketide hybride molecules. There are no data on the toxicity of these compounds.

Maltoryzin {#Sec58}
----------

The polyketide maltoryzin was reported from a strain of *A. oryzae* var. "*microsporis*" isolated from malting barley (Iizuka and Iida [@CR182]). However, the fungus could also be an *Aspergillus clavatus*, which is very common in malting barley (Lopez Diaz and Flannigan [@CR259]). *A. oryzae* or *A. flavus* has not been reported from malting barley. On the other hand, Bakhali et al. ([@CR26]) reported on maltoryzin production by *A. flavus* from walnuts.

Miyakamides {#Sec59}
-----------

Miyakamides A~1~, A~2~, B~1~, and B~2~ (Shiomi et al. [@CR416]), and oryzamide A~1--2~ (Rank et al. [@CR368]) have been reported from both *Aspergillus flavus* "var. *columnaris*" FKI-0739 and *A. oryzae* RIB40 and are NRPs. The miyakamides are antimicrobial compounds, but there are no toxicity data on these compounds. Since the *A. flavus* strain FKI-0739 produced hydroxyaspergillic acid also (Shiomi et al. [@CR416]), it was probably an *A. flavus* sensu stricto. As discussed earlier, RIB40 may also in reality be an *A. flavus* sensu stricto.

Oryzaeins {#Sec60}
---------

The polyketides oryzaein A--D, tabaisocoumarin A, caudacoumarin C, versicolol B, and exserolide D and F are antiviral and cytotoxic isocoumarin derivatives isolated from a fungus identified as *A. oryzae* isolated from the rhizome of the marine *Paris polyphylla* var. *yunnanensis* (Zhou et al. [@CR528]), and thus, the producing strain is probably an *A. flavus* sensu stricto. However, compounds with isochroman chromophores have been found in extracts of some *A. oryzae* (Frisvad JC, "personal data"). The four oryzaeins had moderate to weak inhibitory effect against some human tumor cell lines (Zhou et al. [@CR528]), but their actual toxicity is unknown.

Oryzines {#Sec61}
--------

Oryzines are maleidrides biosynthetically produced from acyl CoA thiolester and from oxaloacetic acid (Wasil et al. [@CR489]). RIB 203, the producing strain, is from sake-koji and thus represents a real *A. oryzae*. There are no data on the bioactivity of these compounds as yet.

Parasiticolides {#Sec62}
---------------

Parasiticolide A = astellolide A is a sesquiterpene that was first found in *Aspergillus parasiticus* from section *Flavi* (Hamasaki et al. [@CR146]) and *Aspergillus stellatus* from section *Nidulantes* (Gould et al. [@CR137]), and later parasiticolide A, dideacetylparasiticolide A, and 14-deacetyl parasiticolide A were isolated from *A. oryzae* RIB40 (Rank et al. [@CR368]). Ren et al. ([@CR375]) found astellolides A, B, C--E, and F--I in *Aspergillus oryzae* QXPV-4 isolated from the insect *Coccinella septempunctata*. The origin of QXPV-4 indicates that this was also an *A. flavus* sensu stricto, rather than an *A. flavus*. Shinohara et al. ([@CR415]) also found parasiticolides = astellolides in *A.oryzae* RIB40: 14-deacetyl astellolide A = 14-deacetyl parasiticolide A (already found by Rank et al. [@CR368]), and 14-deacetyl astellolide B. Depending on the opinion of the taxonomic status of *A. flavus* and *A. oryzae*, parasiticolides are secondary metabolites of one of these species or both.

Penicillins {#Sec63}
-----------

Penicillins are non-ribosomally synthesized tripeptides (NRP) that have been reported from *A. oryzae* (Waksman and Bugie [@CR485]; Foster and Karow [@CR101]; Marui et al. [@CR279]) and *A. flavus* originally as flavicidin (Bush and Goth [@CR51]; McKee and MacPhillamy [@CR288]; McKee et al. [@CR289]; Waksman and Bugie [@CR485]; RG Benedict, unpublished in Raper [@CR372]). This important antibiotic is not regarded as a mycotoxin, but it is unwanted in industrial fermentations due to its wide use to treat microbial infections.

Pseurotins {#Sec64}
----------

Pseurotins are hybrid NRP/PKS compounds that have been found in *A. leporis* and *A. nomius* from *Aspergillus* section *Flavi* (Varga et al. [@CR475]) and were also reported from *A*. "*oryzae*" MMAO1 (Shaaban et al. [@CR409]) and *A. flavus* (Rodríguez et al. [@CR378]). The pseurotins are not regarded as mycotoxins, but these compounds should be examined in more detail, as they have neuritogenic (Komagata et al. [@CR227]), antibiotic (Mehedi et al. [@CR290]; Pinheiro et al. [@CR347]), anti-inflammatory (Shi et al. [@CR411]), chitin-synthase inhibitor (Wenke et al. [@CR491]), and antileishmanial and anticancer (Martinez-Luis et al. [@CR278]) characteristics.

Sporogens {#Sec65}
---------

Sporogen AO1 (=13-desoxyphomenone) is a sesquiterpenoid that was isolated from *Aspergillus oryzae* NOY-2, but the strain is not available to the scientific community. This compound induces conidiation in a less sporulating strain (Tanaka et al. 1984,b). Sporogen AO1 has later been found in strains of *A. flavus* (Frisvad and Larsen, unpublished). Phomenone, related to sporogen AO1, is a potent inhibitor of protein synthesis (Moule et al. [@CR304]) and has moderate toxicity to shrimps (Capasso et al. [@CR56]). Phomenone was recently shown to stimulate pro-inflammatory responses in murine cells and thus may exacerbate allergic reactions if inhaled (Rand et al. [@CR367]). There are no direct data showing that these compounds are mycotoxins, but they are not unlike the mycotoxin PR-toxin in structure (Cole and Cox [@CR72]; Moule et al. [@CR304]; Capasso et al. [@CR56]). Many of the sporogens are phytotoxins (Daengrot et al. [@CR78]).

TMC-2A, -2B and -2C {#Sec66}
-------------------

The NRP-derived peptide-like compounds TMC-2A, -2B, and 2C were isolated from a strain identified as *A. oryzae* A374 = FERM P-14934 (Nonaka et al. [@CR327]; Asai et al. [@CR15]). From the description of the strain, and as it was isolated from soil, it appears that the strain is rather an *Aspergillus tamarii*, as the conidia were large, distinctly roughened, and brown. These peptide-like compounds may be used as lead compounds to find better rheumatoid arthritis inhibitors, but toxicity data have not been presented.

Tryptophenalins {#Sec67}
---------------

A fungus identified as *A. oryzae* (MMAO1) was isolated from rice hulls, and this fungus produced a dimeric diketopiperazine compound, ditryptophenaline, 7,9-dihydroxy-3-(1H-indol-3-ylmethyl)-8-methoxy-2,3,11,11a-tetrahydro-6H-pyrazino\[1,2-b\]isoquinoline-1,4-dione, cyclo-(Trp-Tyr), cyclo-(Pro-Val), α-cyclopiazonic acid, (bismethylthio)gliotoxin, pseurotin A, kojic acid, linoleic acid, and uridine (Shaaban et al. [@CR409]). Since the isolate was from rice hulls in a domesticated field, it was probably an *A. flavus*, but it could also be an *A. nomius* since pseurotin A has only been found once in *A. flavus* (see Varga et al. [@CR475]; Rodríguez et al. [@CR378]). Ditryptoleucine, related to ditryptophenaline from *A. flavus* (Springer et al. [@CR422]) was isolated from *A. oryzae* RIB40 (Rank et al. [@CR368]). The toxicity of the diketopiperazines cyclo-(Trp-Tyr), cyclo-(Pro-Val) is unknown. The monomer of ditryptophenaline, cyclo-N-methylphenyl-alanyltryptophanyl has also been isolated (Kozlovskii et al. [@CR232]).

Ustilaginoidins {#Sec68}
---------------

The polyketide ustilaginoidin C was isolated as a suggested conidium pigment from *A. parasiticus* (Brown et al. [@CR45]), and a compound with the same chromophore has been isolated from *A. flavus* (Frisvad, JC, unpublished data), so it could be representing the general naphtho-γ-pyrone pigment type produced in *Aspergillus* section *Flavi*. There are no toxicity data on these compounds.

Ustiloxin B {#Sec69}
-----------

This ribosomally produced cyclic peptide (RIPS, ribosomally produced peptides) compound was isolated from *Aspergillus flavus* and *A. oryzae* (Umemura et al. 2013, b, 2014; Ye et al. [@CR507]; Yoshimi et al. [@CR509]). The ustiloxins are phytotoxins first isolated from *Villosiclava virens* (= *Ustilaginoidea virens*), and they exibit potent antimitotic activity and inhibit microtubule assembly (Koiso et al. [@CR225]), and they have also been called mycotoxins (Koiso et al. [@CR226]). The ustiloxins are not established as mycotoxins. *A. oryzae* RIB40 does not produce ustiloxin B, probably because of the large deletion of the ustR gene encoding a transcriptional regulation that regulates ustiloxin B production (Umemura et al. [@CR468]).

Secondary metabolites that are not produced by *A. flavus* or *A. oryzae* {#Sec70}
-------------------------------------------------------------------------

Due to the close relatedness between *A. flavus* and *A. oryzae* as well as their similarity to other species, some reports have misleadingly described production of secondary metabolites in *A. flavus* or *A. oryzae* that they do not produce (Table [8](#Tab8){ref-type="table"}).

Secondary metabolites described in *T. reesei* {#Sec71}
----------------------------------------------

Peptaibol non-ribosomal peptides (peptaibiotics) and similar peptides are produced by many *Trichoderma* species (Zeilinger et al. [@CR514]), but it is only paracelsin A, C, and D in this class that have been reported from *T. reesei* (Brückner and Graf [@CR46]; Brückner et al. [@CR47]; Pócsfalvi et al. [@CR350]; Przybylski et al. [@CR356]). The paracelsins were reported from an authentic strain of *T. reesei* (QM 9414 (mutant of QM 6a) = ATCC 26421 = CBS 392.92 and the wild ex type strain from cotton duck shelter, Bougainville Island QM 6a (= ATCC 13631 = CBS 383.78). Paracelsins are linear peptides containing a high level of uncommon amino acids, alphaaminoisobutyric acid (Aib), and isovaline (Iva), together with an acetylated N-terminal amino acid and a C-terminal amino alcohol (Pócsfalvi et al. [@CR350]). These compounds have shown antimicrobial activity. There are no data on the toxicity of the paracelsins.

The sorbicillin biosynthetic family compounds have been reported from *Trichoderma* sp. USF 2690 (Abe et al. [@CR5]) (strain not available in any culture collection), and it is only mentioned to be a product of *T. reesei* in the Antibase secondary metabolite database. The Trichodermatides (A--D) are produced by a fungus claimed to be a marine *T. reesei* (Sun et al. [@CR428]; Shigehisa et al. [@CR412]), but the culture is unavailable in culture collections, and may be one of the many other known *Trichoderma* species. *T. reesei* may also produce some other non-ribosomal peptides, including intracellular and extracellular siderophores (Zeilinger et al. [@CR514]). Siderophores such as ferricrocin have not been claimed to be toxic. Among the polyketides, the genes for a conidium pigment related to aurofusarin and bikaverin have been reported (Zeilinger et al. [@CR514]). This polyketide compound (not structure elucidated) is probably a precursor for the green pigment (melanin) in the conidia of *T. reesei*, and generally, these conidium pigments have not been claimed to be toxic. *T. reesei* have PKS gene clusters for production of other polyketides, which are not unlike those for citrinin and fumonisins (Baker et al. [@CR25]), but neither citrinin nor fumonisins have been detected in *T. reesei*. In conclusion, the only secondary metabolites that appear to be naturally produced by *T. reesei* are the paracelsins.

Based on genome sequencing data (Schmoll et al. [@CR403]), several potential toxic secondary metabolites may be produced under special conditions. Such secondary metabolites have not been detected yet in *T. reesei*, however. Genome sequencing showed that there are 8 NRKS, 11 PKS, 2 NRPS-PKS hybrid, and 12 terpenoid synthase encoding genes (Schmoll et al. [@CR403]; Zeilinger et al. [@CR514]). The *LaeA* and VELVET regulatory genes are important for the expression of secondary metabolites in *T. reesei*, but nevertheless, only few of the putative gene clusters for secondary metabolites seem to be actually expressed.

Conclusions {#Sec72}
===========

*Aspergillus oryzae* produce few recognized mycotoxins, and they are only produced by few strains. If they are produced, there are genetic means of inactivating the biosynthetic pathways, so isolates of the species can be exploited for production of enzymes and as a transformation host for industrially relevant secondary metabolites or enzymes. Some isolates of *Aspergillus niger* can produce three types of mycotoxins, ochratoxin A, fumonisin B~2~ (B~4~ and B~6~), and oxalic acid. Again, genetic means have been employed to inactivate the gene clusters for ochratoxins and fumonisins, while accumulation of the less toxic oxalic acid can be avoided by chosing an optimal substrate or use optimal procedures for the industrial products. *Trichoderma reesei* cannot produce any recognized mycotoxins and is one of the most important enzyme producers in the industry. All three species can produce interesting secondary metabolites, of which some are drug lead candidates and others, such as citric acid, are important bulk chemicals that are produced by fermentation.
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